Gelesis (GLSHQ) S-4/A13 Dec 21Registration of securities issued in business combination transactions (amended)Financial data

Company Profile

Document and Entity Information

Document and Entity Information	9 Months Ended
Document and Entity Information	Sep. 30, 2021
Document and Entity Information
Document Type	S-4/A
Entity Registrant Name	CAPSTAR SPECIAL PURPOSE ACQUISITION CORP.
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Central Index Key	0001805087
Amendment Flag	true
Amendment Description	Amendment No. 5

BALANCE SHEET

BALANCE SHEET - USD ($)	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jul. 07, 2020	Jun. 30, 2020	Mar. 31, 2020	Feb. 14, 2020	Feb. 13, 2020
Current Assets
Cash	$ 304,944			$ 491,827
Prepaid expenses	39,816			65,973
Total Current Assets	344,760			557,800
Cash and marketable securities held in Trust Account	276,178,675			276,209,453
Total Assets	276,523,435			276,767,253
LIABILITIES AND STOCKHOLDERS' DEFICIT
Accounts payable and Accrued expenses				1,630,832
Warrant liability	32,386,148			30,101,808	$ 17,081,700	$ 17,695,600
Deferred underwriting fee payable	9,660,000			9,660,000		9,660,000
Total Liabilities	44,806,220			41,392,640
Commitments
Class A Common Stock Subject to Possible Redemption	276,028,675			276,033,447	276,087,639	276,000,000
Stockholders' Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	0			0
Additional paid-in capital	0			0
Accumulated deficit	(44,312,150)			(40,659,524)	(25,533,547)	$ (26,004,118)
Total Stockholders' Deficit	(44,311,460)	$ (30,073,974)	$ (26,026,715)	(40,658,834)	$ (25,532,857)		$ 24,000	$ 24,000	$ 0	$ 0
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	276,523,435			276,767,253
Class A common stock
Stockholders' Deficit
Common stock	0			0
Class B common stock
Stockholders' Deficit
Common stock	$ 690			$ 690

BALANCE SHEET (Parenthetical)

BALANCE SHEET (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020	Feb. 26, 2020
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A common stock
Ordinary shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	100,000,000	100,000,000	100,000,000
Ordinary shares, shares issued	0	0
Ordinary shares, shares outstanding	0	0
Temporary Equity, Shares Outstanding		27,600,000
Class B common stock
Ordinary shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	10,000,000	10,000,000	10,000,000
Ordinary shares, shares issued	6,900,000	6,900,000
Ordinary shares, shares outstanding	6,900,000	6,900,000

STATEMENT OF OPERATIONS

STATEMENT OF OPERATIONS - USD ($)	2 Months Ended		3 Months Ended						8 Months Ended	9 Months Ended	11 Months Ended
STATEMENT OF OPERATIONS - USD ($)	Mar. 31, 2020	Mar. 31, 2020	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Formation and operating costs											$ 2,426,204
Loss from operations			$ (1,113,342)				$ (184,615)		$ (185,615)	$ (1,518,286)	(2,426,204)
Other income:
Interest earned on marketable securities held in Trust Account			138,117				96,143		96,143	142,997	201,441
Unrealized gain on marketable securities held in Trust Account			(106,039)				41,496		41,496	2,231	8,012
Change in fair value of warrant liability			(13,174,144)				613,900		613,900	(2,284,340)	(12,406,208)
Transaction costs incurred in connection with warrant liability									671,901		(671,901)
Total other income (expense), net			(13,142,066)				79,638		79,638	(2,139,112)	(12,868,656)
Net loss	$ (1,000)	$ (1,000)	$ (14,255,408)	$ (4,088,974)	$ 14,686,984	$ (15,180,169)	$ (113,691)	$ 0	$ (114,691)	$ (3,657,398)	$ (15,294,860)
Basic and diluted weighted average shares outstanding, Class A Common Stock											24,524,620
Basic and diluted net loss per share, Class A common stock											$ 0
Basic and diluted weighted average shares outstanding, Class B common stock											8,269,814
Basic and diluted net income per share, Class B common stock											$ (1.85)
Class A common stock
Other income:
Basic and diluted weighted average shares outstanding, Class A Common Stock											15,758,710
Basic and diluted net loss per share, Class A common stock											$ (0.69)
Basic and diluted weighted average shares outstanding, Class B common stock			27,600,000				25,780,220		10,761,468	27,600,000	15,758,710
Basic and diluted net income per share, Class B common stock			$ (0.41)				$ 0		$ (0.01)	$ (0.11)	$ (0.69)
Class B common stock
Other income:
Basic and diluted weighted average shares outstanding, Class B common stock			6,900,000				6,840,659		6,350,917	6,900,000	6,513,871
Basic and diluted net income per share, Class B common stock			$ (0.41)				$ 0		$ (0.01)	$ (0.11)	$ (0.69)

STATEMENT OF CHANGES IN STOCKHO

STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Class A common stockCommon Stock	Class B common stockCommon Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Feb. 13, 2020	$ 0	$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Feb. 13, 2020	0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B common stock to Sponsor		$ 690	24,310		25,000
Issuance of Class B common stock to Sponsor (in shares)		6,900,000
Net loss				(1,000)	(1,000)
Balance at the end at Mar. 31, 2020		$ 690	24,310	(1,000)	24,000
Balance at the end (in shares) at Mar. 31, 2020		6,900,000
Balance at the beginning at Feb. 13, 2020	$ 0	$ 0	0	0	$ 0
Balance at the beginning (in shares) at Feb. 13, 2020	0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of Units, net of underwriting discounts (in shares)					27,600,000
Net loss					$ (114,691)
Balance at the end at Sep. 30, 2020		$ 690		(25,533,547)	(25,532,857)
Balance at the end (in shares) at Sep. 30, 2020		6,900,000
Balance at the beginning at Feb. 13, 2020	$ 0	$ 0	0	0	$ 0
Balance at the beginning (in shares) at Feb. 13, 2020	0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale of Units, net of underwriting discounts (in shares)					27,600,000
Net loss					$ (15,294,860)
Balance at the end at Dec. 31, 2020		$ 690		(40,659,524)	(40,658,834)
Balance at the end (in shares) at Dec. 31, 2020		6,900,000
Balance at the beginning at Feb. 14, 2020		$ 0	0	0	0
Balance at the beginning (in shares) at Feb. 14, 2020		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B common stock to Sponsor		$ 690	24,310		25,000
Issuance of Class B common stock to Sponsor (in shares)		6,900,000
Net loss				(1,000)	(1,000)
Balance at the end at Mar. 31, 2020		$ 690	24,310	(1,000)	24,000
Balance at the end (in shares) at Mar. 31, 2020		6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		$ 0	0	0	0
Balance at the end at Jun. 30, 2020		$ 690	24,310	(1,000)	24,000
Balance at the end (in shares) at Jun. 30, 2020		6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A ordinary share subject to redemption amount			1,302,710	25,418,856	26,721,566
Cash paid in excess of fair value of Private Placement Warrants			$ 1,278,400		1,278,400
Net loss				(113,691)	(113,691)
Balance at the end at Sep. 30, 2020		$ 690		(25,533,547)	(25,532,857)
Balance at the end (in shares) at Sep. 30, 2020		6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A ordinary share subject to redemption amount				54,192	54,192
Net loss				(15,180,169)	(15,180,169)
Balance at the end at Dec. 31, 2020		$ 690		(40,659,524)	(40,658,834)
Balance at the end (in shares) at Dec. 31, 2020		6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A ordinary share subject to redemption amount				54,865	54,865
Net loss				14,686,984	14,686,984
Balance at the end at Mar. 31, 2021		$ 690		(26,027,405)	(26,026,715)
Balance at the end (in shares) at Mar. 31, 2021		6,900,000
Balance at the beginning at Dec. 31, 2020		$ 690		(40,659,524)	(40,658,834)
Balance at the beginning (in shares) at Dec. 31, 2020		6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss					(3,657,398)
Balance at the end at Sep. 30, 2021		$ 690		(44,312,150)	(44,311,460)
Balance at the end (in shares) at Sep. 30, 2021		6,900,000
Balance at the beginning at Mar. 31, 2021		$ 690		(26,027,405)	(26,026,715)
Balance at the beginning (in shares) at Mar. 31, 2021		6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A ordinary share subject to redemption amount				(41,715)	(41,715)
Net loss				(4,088,974)	(4,088,974)
Balance at the end at Jun. 30, 2021		$ 690		(30,074,664)	(30,073,974)
Balance at the end (in shares) at Jun. 30, 2021		6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A ordinary share subject to redemption amount				(17,922)	(17,922)
Net loss				(14,255,408)	(14,255,408)
Balance at the end at Sep. 30, 2021		$ 690		$ (44,312,150)	$ (44,311,460)
Balance at the end (in shares) at Sep. 30, 2021		6,900,000

STATEMENT OF CHANGES IN STOCK_2

STATEMENT OF CHANGES IN STOCKHOLDERS' DEFICIT (Parenthetical) - shares	8 Months Ended	11 Months Ended
	Sep. 30, 2020	Dec. 31, 2020
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' EQUITY (DEFICIT)
Sale of 27,600,000 Units, net of underwriting discounts (in shares)	27,600,000	27,600,000

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS	11 Months Ended
STATEMENT OF CASH FLOWS	Dec. 31, 2020USD ($)
Cash Flows from Operating Activities:
Net loss	$ (15,294,860)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(201,441)
Unrealized gain on marketable securities held in Trust Account	(8,012)
Change in fair value of warrant liability	12,406,208
Transaction costs incurred in connection with warrant liability	671,901
Changes in operating assets and liabilities:
Prepaid expenses	(65,973)
Accrued expenses	1,630,832
Net cash used in operating activities	(861,345)
Cash Flows from Investing Activities:
Investment of cash in Trust Account	(276,000,000)
Net cash provided by (used in) investing activities	(276,000,000)
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000
Proceeds from sale of Units, net of underwriting discounts paid	270,480,000
Proceeds from sale of Private Placement Warrants	7,520,000
Proceeds from promissory note - related party	150,000
Repayment of promissory note - related party	(150,000)
Payment of offering costs	(671,828)
Net cash provided by financing activities	277,353,172
Net Change in Cash	491,827
Cash - Beginning of period	0
Cash - End of period	491,827
Non-cash investing and financing activities:
Initial classification of Class A common stock subject to possible redemption	276,000,000
Change in value of Class A common stock subject to possible redemption	33,447
Deferred underwriting fee payable	9,660,000
Initial classification of warrant liability	$ 17,695,600

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	9 Months Ended	11 Months Ended
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	Sep. 30, 2021	Dec. 31, 2020
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATION S Capstar Special Purpose Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on February 14, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the consumer, healthcare and technology, media and telecommunications (“TMT”) industries. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has one wholly-owned subsidiary, CPSR Gelesis Merger Sub, Inc., which was incorporated in the State of Delaware on July 2, 2021 (“Merger Sub”). As of September 30, 2021, the Company had not commenced any operations. All activity through September 30, 2021 relates to the Company’s formation, its initial public offering (“Initial Public Offering”), which is described below, the search for a target company for a Business Combination and activities in connection with the proposed business combination with Gelesis, Inc., a Delaware corporation (“Gelesis”) (see Note 7). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the marketable securities held in the Trust Account. The registration statement for the Company’s Initial Public Offering was declared effective on July 1, 2020. On July 7, 2020, the Company consummated the Initial Public Offering of 27,600,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,520,000 warrants (each, a “Private Placement Warrant” and, collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Capstar Sponsor Group, LLC (the “Sponsor”), generating gross proceeds of $7,520,000, which is described in Note 5. Transaction costs amounted to $15,851,828, consisting of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees and $671,828 of other offering costs. Following the closing of the Initial Public Offering on July 7, 2020, an amount of $276,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”). The proceeds are held in the Trust Account located in the United States and shall be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the funds in the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (excluding taxes payable on interest income earned from the Trust Account and the deferred underwriting commissions) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to public stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law or stock exchange requirements and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (i) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (ii) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their shares in conjunction with any such amendment. The Company will have until July 7, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten The Sponsor has agreed to waive its right to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these condensed consolidated financial statements. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Liquidity and Management’s Plan As of September 30, 2021, the Company had $304,944 in its operating bank accounts, $276,178,675 in securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital deficit of $2,265,312, which excludes $150,000 of franchise taxes payable. On July 28, 2021, the Sponsor committed to provide the Company an aggregate of $4,000,000 in loans for working capital purposes (see Note 6). These loans will be non-interest bearing, unsecured and will be repaid upon the consummation of a Business Combination. If the Company does not consummate a Business Combination, all amounts loaned to the Company in connection with these loans will be forgiven except to the extent that the Company has funds available to it outside of its Trust Account. As a result, management has determined that sufficient capital exists to sustain operations through the earlier of the consummation of a Business Combination or July 7, 2022, the scheduled liquidation date of the Company if a Business Combination is not completed.	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Capstar Special Purpose Acquisition Corp. (the “Company”) was incorporated in Delaware on February 14, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the consumer, healthcare and technology, media and telecommunications (“TMT”) industries. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2020, the Company had not commenced any operations. All activity for the period from February 14, 2020 (inception) through December 31, 2020 relates to the Company’s formation, its initial public offering (“Initial Public Offering”), which is described below, and the search for a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on July 1, 2020. On July 7, 2020, the Company consummated the Initial Public Offering of 27,600,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,520,000 warrants (each, a “Private Placement Warrant” and, collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Capstar Sponsor Group, LLC (the “Sponsor”), generating gross proceeds of $7,520,000, which is described in Note 5. Transaction costs amounted to $15,851,828, consisting of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees and $671,828 of other offering costs. Following the closing of the Initial Public Offering on July 7, 2020, an amount of $276,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”). The proceeds are held in the Trust Account located in the United States and shall be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the funds in the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (excluding taxes payable on interest income earned from the Trust Account and the deferred underwriting commissions) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to public stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law or stock exchange requirements and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (i) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (ii) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their shares in conjunction with any such amendment. The Company will have until July 7, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten The Sponsor has agreed to waive its right to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Liquidity and Management’s Plan As of December 31, 2020, the Company had $491,827 in its operating bank accounts, $276,209,453 in securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital deficit of $897,026, which excludes $176,006 of franchise taxes payable. As of December 31, 2020, approximately $209,000 of the amount on deposit in the Trust Account represented interest income, which is available to pay the Company’s tax obligations. As of December 31, 2020, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements and had substantial doubt over its ability to continue as a going concern. On March 3, 2021 (see Note 12), the Sponsor committed to provide the Company an aggregate of $1,500,000 in loans for working capital purposes. Accordingly, management has since reevaluated the Company’s liquidity and financial condition and determined that sufficient capital exists to sustain operations for at least one year from the issuance date of these financial statements and therefore substantial doubt has been alleviated.

RESTATEMENT OF PREVIOUSLY ISSUE

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	11 Months Ended
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2 — RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS Amendment 1 The Company previously accounted for its outstanding Public Warrants (as defined in Note 4) and Private Placement Warrants (collectively, with the Public Warrants, the “Warrants”) issued in connection with its Initial Public Offering as components of equity instead of as derivative liabilities. The warrant agreement governing the Warrants includes a provision that provides for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant. In addition, the warrant agreement includes a provision that in the event of a tender offer or exchange offer made to and accepted by holders of more than 50% of the outstanding shares of a single class of stock, all holders of the Warrants would be entitled to receive cash for their Warrants (the “tender offer provision”). On April 12, 2021, the staff of the Division of Corporation Finance of the Securities and Exchange Commission issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled “Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Statement”). Specifically, the SEC Statement focused on certain settlement terms and provisions related to certain tender offers following a business combination, which terms are similar to those contained in the warrant agreement, dated as of July 7, 2020, between the Company and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent (the “Warrant Agreement”). In further consideration of the SEC Statement, the Company’s management further evaluated the Warrants under Accounting Standards Codification (“ASC”) Subtopic 815-40, Contracts in Entity’s Own Equity. ASC Section 815-40-15 addresses equity versus liability treatment and classification of equity-linked financial instruments, including warrants, and states that a warrant may be classified as a component of equity only if, among other things, the warrant is indexed to the issuer’s common stock. Under ASC Section 815-40-15, a warrant is not indexed to the issuer’s common stock if the terms of the warrant require an adjustment to the exercise price upon a specified event and that event is not an input to the fair value of the warrant. Based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the Company’s Warrants are not indexed to the Company’s common stock in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. In addition, based on management’s evaluation, the Company’s audit committee, in consultation with management, concluded that the tender offer provision fails the “classified in stockholders’ equity” criteria as contemplated by ASC Section 815-40-25. As a result of the above, the Company should have classified the Warrants as derivative liabilities in its previously issued financial statements. Under this accounting treatment, the Company is required to measure the fair value of the Warrants at the end of each reporting period as well as re-evaluate the treatment of the warrants (including on July 7, 2020, September 30, 2020 and December 31, 2020) and recognize changes in the fair value from the prior period in the Company’s operating results for the current period. The Company’s accounting for the Warrants as components of equity instead of as derivative liabilities did not have any effect on the Company’s previously reported cash or investments held in the trust account. Amendment 2 In connection with the preparation of the Company’s condensed consolidated financial statements as of September 30, 2021, management identified errors made in its historical financial statements where, at the closing of the Company’s Initial Public Offering, the Company improperly valued its Class A common stock subject to possible redemption. The Company previously determined the Class A common stock subject to possible redemption to be equal to the redemption value, while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Management determined that the Public Shares underlying the Units issued during the Initial Public Offering can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control. Therefore, management concluded that temporary equity should include all shares of Class A common stock subject to possible redemption, resulting in the Class A common stock subject to possible redemption being equal to their redemption value. As a result, management has noted a classification error related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the Class A common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Class A common stock. In connection with the change in presentation for the Class A common stock subject to possible redemption, the Company also restated its income (loss) per common share calculation to allocate net income (loss) evenly to Class A and Class B common stock. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of common stock share pro rata in the income (loss) of the Company. There has been no change in the Company’s total assets, liabilities or operating results. As As As Previously Adjustments Restated Adjustments Restated Reported (Amendment 1) (Amendment 1) (Amendment 2) (Amendment 2) Balance sheet as of July 7, 2020 (unaudited) Warrant Liability $ — $ 17,695,600 $ 17,695,600 $ — $ 17,695,600 Class A Common Stock Subject to Possible Redemption 262,692,170 (17,695,600) 244,996,570 31,003,430 276,000,000 Class A Common Stock 133 177 310 (310) — Additional Paid-in Capital 5,000,179 671,724 5,671,903 (5,671,903) — Accumulated Deficit (1,000) (671,901) (672,901) (25,331,217) (26,004,118) Balance sheet as of September 30, 2020 (unaudited) Warrant Liability $ — $ 17,081,700 $ 17,081,700 $ — $ 17,081,700 Class A Common Stock Subject to Possible Redemption 262,636,479 (17,081,700) 245,554,779 30,532,860 276,087,639 Class A Common Stock 134 171 305 (305) — Additional Paid-in Capital 5,055,869 57,830 5,113,699 (5,113,699) — Accumulated Deficit (56,690) (58,001) (114,691) (25,418,856) (25,533,547) Balance sheet as of December 31, 2020 (audited) Warrant Liability $ — $ 30,101,808 $ 30,101,808 $ — 30,101,808 Class A Common Stock Subject to Possible Redemption 260,476,412 (30,101,808) 230,374,604 45,658,843 276,033,447 Common Stock 156 301 457 (457) — Additional Paid-in Capital 7,215,914 13,077,808 20,293,722 (20,293,722) — Accumulated Deficit (2,216,751) (13,078,109) (15,294,860) (25,364,664) (40,659,524) Statement of Operations for the Period from February 14, 2020 (inception) to September 30, 2020 (unaudited) Change in fair value of warrant liability $ — $ 613,900 $ 613,900 — 613,900 Transaction costs associated with Initial Public Offering — (671,901) (671,901) — (671,901) Net loss (56,690) (58,001) (114,691) — (114,691) Weighted average shares outstanding, Common stock subject to possible redemption 26,269,217 (1,769,560) 24,499,657 (24,499,657) — Basic and diluted net income per share, Common stock subject to possible redemption 0.00 — 0.00 — — Weighted average shares outstanding, Non-redeemable common stock 6,869,801 689,966 7,559,767 (7,559,767) — Basic and diluted net loss per share, Non-redeemable common stock (0.02) — (0.02) 0.02 — Weighted average shares outstanding of Class A common stock — — — 10,761,468 10,761,468 Basic and diluted net loss per share, Class A common stock — — — (0.01) (0.01) Weighted average shares outstanding of Class B common stock — — — 6,350,917 6,350,917 Basic and diluted net loss per share, Class B common stock — — — (0.01) (0.01) Statement of Operations for the Period from February 14, 2020 (inception) to December 31, 2020 (audited) Change in fair value of warrant liability $ — $ (12,406,208) $ (12,406,208) — (12,406,208) Transaction costs associated with Initial Public Offering — (671,901) (671,901) — (671,901) Net loss (2,216,751) (13,078,109) (15,294,860) — (15,294,860) Weighted average shares outstanding, Common stock subject to possible redemption 26,261,989 (1,737,369) 24,524,620 (24,524,620) — Basic and diluted net income per share, Common stock subject to possible redemption 0.00 — 0.00 — — Weighted average shares outstanding, Common stock 7,273,705 1,010,362 8,269,814 (8,269,814) — Basic and diluted net loss per share, Common stock (0.31) (1.54) (1.85) 1.85 — Weighted average shares outstanding of Class A common stock — — — 15,758,710 15,758,710 Basic and diluted net loss per share, Class A common stock — — — (0.69) (0.69) Weighted average shares outstanding of Class B common stock — — — 6,513,871 6,513,871 Basic and diluted net loss per share, Class B common stock — — — (0.69) (0.69) Basic and diluted net loss per share, Class B common stock — — — (0.69) (0.69) Statement of Changes in Stockholders’ Equity (Deficit) for the Period from February 14, 2020 (inception) to September 30, 2020 (audited) Sales of 27,600,000 Units, net of underwriting discounts 249,366,073 — — (249,366,073) — Class A common stock subject to possible redemption (245,554,775) — — 245,554,775 — Accretion for Class A common stock subject to redemption amount — — — (26,721,566) (26,721,566) Total stockholders’ equity (deficit) 5,000,003 — — (30,532,860) (25,532,857) Statement of Changes in Stockholders’ Equity (Deficit) for the Period from February 14, 2020 (inception) to December 31, 2020 (audited) Sales of 27,600,000 Units, net of underwriting discounts 249,366,073 — — (249,366,073) — Class A common stock subject to possible redemption (230,374,604) — — (230,374,604) — Accretion for Class A common stock subject to redemption amount — — — (26,721,566) (26,721,566) Total stockholders’ equity (deficit) 5,000,009 — — (45,658,843) (46,658,834) Cash Flow Statement for the Period from February 14, 2020 (inception) to September 30, 2020 (unaudited) Net loss (56,690) (58,001) (114,691) — (114,691) Change in fair value of warrant liability $ — $ (613,900) $ (613,900) — (613,900) Transaction costs associated with Initial Public Offering — 671,901 671,901 — 671,901 Initial classification of Class A common stock subject to possible redemption 262,692,170 (17,695,600) 244,996,570 31,003,430 276,000,000 Change in value of Class A common stock subject to possible redemption (55,691) 613,900 558,209 (470,570) 87,639 Cash Flow Statement for the Period from February 14, 2020 (inception) to December 31, 2020 (audited) Net loss (2,216,751) (13,078,109) (15,294,860) — (15,294,860) Change in fair value of warrant liability $ — $ (12,406,208) $ (12,406,208) — (12,406,208) Transaction costs associated with Initial Public Offering — (671,901) (671,901) — (671,901) Initial classification of Class A common stock subject to possible redemption 262,692,170 (17,695,600) 244,996,570 31,003,430 276,000,000 Change in value of Class A common stock subject to possible redemption (2,215,758) (12,406,208) (14,621,966) 14,655,413 33,447

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended	11 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Sep. 30, 2021	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated under the Securities Act. Certain information or footnote disclosures normally included in condensed consolidated financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K/A, as filed with the SEC on July 8, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any future periods. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed consolidated financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020. Marketable Securities Held in Trust Account At September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed consolidated balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed consolidated statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. Warrant Liabilities The Company accounts for the Public Warrants (as defined in Note 3) and Private Placement Warrants (together with the Public Warrants, the “Warrants”) in accordance with the guidance contained in ASC 815-40, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value in respect of each reporting period. This liability is subject to re-measurement at each balance sheet date until the Warrants are exercised, and any change in fair value is recognized in the statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date. Class A Common Stock Subject to Possible Redemption The Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed consolidated balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid-in capital and accumulated deficit. At September 30, 2021 and December 31, 2020, the ordinary shares reflected in the condensed consolidated balance sheets are reconciled in the following table: Gross proceeds $ 276,000,000 Less: Proceeds allocated to Public Warrants (11,454,000) Ordinary shares issuance costs (15,179,714) Plus: Accretion of carrying value to redemption value 26,667,374 Ordinary shares subject to possible redemption, 12/31/20 276,033,447 Accretion of carrying value to redemption value (4,772) Ordinary shares subject to possible redemption, 9/30/21 $ 276,028,675 Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The effective tax rates differ from the statutory tax rate for the periods presented primarily due to the change in warrant valuation and the valuation allowance recorded on the Company’s net operating losses. ASC 740 prescribes a recognition threshold and a measurement attribute for the condensed consolidated financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the two-class method in calculating income (loss) per common share. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share as the redemption value approximates fair value. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 21,320,000 shares in the calculation of diluted income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events. As of September 30, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Period from Three Months Ended Nine Months Ended Three Months Ended February 14, September 30, September 30, September 30, 2020 (Inception) Through 2021 2021 2020 September 30, 2020 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per common share Numerator: Allocation of net income (loss), as adjusted $ (11,404,326) $ (2,851,082) $ (2,925,918) $ (731,480) $ (89,850) $ (23,841) $ (72,126) $ (42,565) Denominator: Basic and diluted weighted average stock outstanding 27,600,000 6,900,000 27,600,000 6,900,000 25,780,220 6,840,659 10,761,468 6,350,917 Basic and diluted net income (loss) per common share $ (0.41) $ (0.41) $ (0.11) $ (0.11) $ (0.00) $ (0.00) $ (0.01) $ (0.01) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature. The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. Recent Accounting Standards In August 2020, the FASB issued ASU No. 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 on January 1,2021. The adoption of ASU 2020-06 did not have an impact on the Company’s condensed consolidated financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020. Marketable Securities Held in Trust Account At December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. Warrant Liability (Restated, see Note 2 — Amendment 1) The Company accounts for the Warrants in accordance with the guidance contained in ASC 815-40-15-7D and 7F under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjust the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date. Class A Common Stock Subject to Possible Redemption (Restated, see Note 2 — Amendment 2) The Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid-in capital and accumulated deficit. At December 31, 2020, the common stock reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 276,000,000 Less: Proceeds allocated to Public Warrants (11,454,000) Class A common stock issuance costs (15,179,927) Plus: Accretion of carrying value to redemption value 26,667,374 Class A common stock subject to possible redemption, 12/31/20 276,033,447 Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”) for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company’s full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements. Net (Loss) per Common Share (Restated, see Note 2 — Amendment 1) Net income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 21,320,000 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statement of operations includes a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net income (loss) per common share, basic and diluted, for Common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to possible redemption outstanding since original issuance. Net income (loss) per share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of non-redeemable common stock outstanding for the period. Non-redeemable common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features. Non-redeemable common stock participates in the income or loss on marketable securities based on non-redeemable shares’ proportionate interest. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts) as previously restated to reflect Amendment 1 only. See Amendment 2 following this amendment to reflect the amounts, as restated, per the financial statements: For the Period from February 14, 2020 (Inception) Through December 31, 2020 Class A Common Stock Subject to Possible Redemption Numerator: Earnings allocable to Class A common stock subject to possible redemption Interest earned on marketable securities held in Trust Account $ 174,810 Less: interest available to be withdrawn for payment of taxes (146,895) Less: interest available to be withdrawn for working capital — Net income attributable to Class A common stock subject to possible redemption $ 27,915 Denominator: Weighted Average Class A common stock subject to possible redemption Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 24,524,620 Basic and diluted net income per share, Class A common stock subject to possible redemption $ 0.00 Non-Redeemable Common Stock Numerator: Net Loss minus Net Earnings Net loss $ (15,294,860) Net income allocable to Class A common stock subject to possible redemption (27,915) Non-Redeemable Net Loss $ (15,322,775) Denominator: Weighted Average Non-redeemable common Stock Basic and diluted weighted average shares outstanding, Non-redeemable common stock 8,269,814 Basic and diluted net loss per share, Non-redeemable common stock $ (1.85) As discussed in Note 2, the financial statements as of December 31, 2020 and for the period from February 14, 2020 (inception) through December 31, 2020 have been restated (Amendment 1 - presentation of warrant liability and Amendment 2 - presentation of class A common stock subject to possible redemption). The information provided under this section was prepared in connection with Amendment 1-presentation of warrant liability, and has been amended and restated in connection with Amendment 2 - presentation of class A common stock subject to possible redemption, as described below under “Net Loss per Common Share (Restated, see Note 1 - Amendment 2)”. Net Loss per Common Share (Restated, see Note 2 — Amendment 2) The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “ Earnings Per Share”. Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company applies the two-class method in calculating income (loss) per common share. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share as the redemption value approximates fair value. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 21,320,000 shares in the calculation of diluted income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events. As of December 31, 2020 and September 31, 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic net loss per common share for the periods presented. The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts), as restated: For the Period from February 14, 2020 (inception) Through December 31, 2020 Class A Class B Basic and diluted net loss per common share Numerator: Allocation of net loss, as adjusted (10,821,703) (4,473,157) Denominator: — Basic and diluted weighted average stock outstanding 15,758,710 6,513,871 Basic and diluted net loss per common share (0.69) (0.69) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Fair Value Measurements (Restated, see Note 2 — Amendment 1) The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

PUBLIC OFFERING

PUBLIC OFFERING	9 Months Ended	11 Months Ended
PUBLIC OFFERING	Sep. 30, 2021	Dec. 31, 2020
PUBLIC OFFERING
PUBLIC OFFERING	NOTE 4. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 27,600,000 Units, which includes the full exercise by the underwriters of their option to purchase an additional 3,600,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one -half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 9).	NOTE 4. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 27,600,000 Units, which includes the full exercise by the underwriters of their option to purchase an additional 3,600,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one -half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).

PRIVATE PLACEMENT

PRIVATE PLACEMENT	9 Months Ended	11 Months Ended
PRIVATE PLACEMENT	Sep. 30, 2021	Dec. 31, 2020
PRIVATE PLACEMENT.
PRIVATE PLACEMENT	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, on July 7, 2020, the Sponsor purchased an aggregate of 7,520,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $7,520,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. The proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants.	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, on July 7, 2020, the Sponsor purchased an aggregate of 7,520,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $7,520,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. The proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended	11 Months Ended
RELATED PARTY TRANSACTIONS	Sep. 30, 2021	Dec. 31, 2020
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On February 26, 2020, the Sponsor purchased 5,750,000 shares of the Company’s Class B common stock (the “Founder Shares”) for an aggregate price of $25,000. On July 1, 2020, the Company effected a stock dividend of 1,150,000 shares, resulting in the Company’s initial stockholders holding an aggregate of 6,900,000 Founder Shares. The Founder Shares included an aggregate of up to 900,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. All share and per-share amounts have been retroactively restated to reflect the stock dividend. As a result of the underwriters’ election to fully exercise their over-allotment option, no Founder Shares are currently subject to forfeiture. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Administrative Support Agreement The Company entered into an agreement, commencing on July 1, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. For the three and nine months ended September 30, 2021, the Company incurred $30,000 and $90,000 in fees for these services, respectively. At September 30, 2021, $10,000 of such fees was included in account payable and accrued expense in the condensed consolidated balance sheet. Promissory Note — Related Party On February 14, 2020, the Sponsor agreed to loan the Company an aggregate of up to $250,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”). The Promissory Note was non-interest bearing and payable on the earlier of July 31, 2020 or the completion of the Initial Public Offering. The outstanding balance under the Promissory Note of $140,000 was repaid at the closing of the Initial Public Offering on July 7, 2020. Borrowings under the Promissory Note are no longer available. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. On March 3, 2021, the Sponsor committed to provide the Company an aggregate of $1,500,000 in loans for working capital purposes on an as needed basis. Such loans will be evidenced by a promissory note when issued. As of September 30, 2021 and December 31, 2020, there were no amounts outstanding under the Working Capital Loans. Sponsor Loan On July 28, 2021, the Sponsor committed to provide the Company an aggregate of $4,000,000 in loans for working capital purposes. These loans will be non-interest bearing, unsecured and will be repaid upon the consummation of a Business Combination. If the Company does not consummate a Business Combination, all amounts loaned to the Company in connection with these loans will be forgiven except to the extent that the Company has funds available to it outside of its Trust Account. As of September 30, 2021, there were no amounts outstanding under these loans.	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On February 26, 2020, the Sponsor purchased 5,750,000 shares of the Company’s Class B common stock (the “Founder Shares”) for an aggregate price of $25,000. On July 1, 2020, the Company effected a stock dividend of 1,150,000 shares, resulting in the Company’s initial stockholders holding an aggregate of 6,900,000 Founder Shares. The Founder Shares included an aggregate of up to 900,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. All share and per-share amounts have been retroactively restated to reflect the stock dividend. As a result of the underwriters’ election to fully exercise their over-allotment option, no Founder Shares are currently subject to forfeiture. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Administrative Support Agreement The Company entered into an agreement, commencing on July 1, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. For the period from February 14, 2020 (inception) through December 31, 2020, the Company incurred and paid $60,000 in fees for these services, of which such amount is included in accrued expenses in the accompanying balance sheet. Promissory Note — Related Party On February 14, 2020, the Sponsor agreed to loan the Company an aggregate of up to $250,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”). The Promissory Note was non-interest bearing and payable on the earlier of July 31, 2020 or the completion of the Initial Public Offering. The outstanding balance under the Promissory Note of $150,000 was repaid at the closing of the Initial Public Offering on July 7, 2020. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants.

COMMITMENTS

COMMITMENTS	9 Months Ended	11 Months Ended
COMMITMENTS	Sep. 30, 2021	Dec. 31, 2020
COMMITMENTS
COMMITMENTS	NOTE 7. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on July 1, 2020, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of the majority of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination, subject to the terms of the underwriting agreement. Business Combination Agreement On July 19, 2021, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “ Business Combination Agreement The Business Combination Agreement and the transactions contemplated thereby were approved by the board of directors of each of the Company and Gelesis. The Business Combination Agreement provides for, among other things, that Merger Sub will merge with and into Gelesis, with Gelesis as the surviving company in the merger and, after giving effect to such merger, Gelesis shall be a wholly-owned subsidiary of the Company (the “Merger ” In accordance with the terms and subject to the conditions of the Business Combination Agreement, at the Effective Time, (i) each share of Gelesis outstanding as of immediately prior to the Effective Time will be exchanged for shares of the Company’s common stock, par value $0.0001 per share (“CPSR Shares”) based on an implied Gelesis equity value of $900,000,000; (ii) all vested and unvested stock options of Gelesis will be assumed by the Company and thereafter be settled or exercisable for CPSR Shares, as applicable, determined based on the same implied Gelesis equity value described in clause (i); (iii) each warrant of Gelesis will be canceled in exchange for a warrant to purchase shares of the Company determined based on the same implied Gelesis equity value described in clause (i); and (iv) each share of the Company’s Class A common stock, par value $0.0001 per share (the “ CPSR Class A Common Stock CPSR Class B Common Stock 20 30 On November 8, 2021, CPSR, Merger Sub and Gelesis entered into an Amendment to the Original Business Combination Agreement (the “Business Combination Agreement Amendment,” and together with the Original Business Combination Agreement, the “Business Combination Agreement”), which, among other things (i) adjusts the equity valuation of Gelesis from $900,000,000 to $675,000,000, (ii) increases the number of Earn Out Shares (as defined in the Business Combination Agreement) available to be issued to Company Stockholders (as defined in the Business Combination Agreement) from 15,000,000 to 23,483,250, (iii) provides for the issuance of 1,983,750 additional Capstar Class A Shares to Company Stockholders, equal to the number of Capstar Class B Shares forfeited by the Sponsor and certain affiliates of the Sponsor in accordance with the Sponsor Letter Agreement Amendment (as defined and described in further detail below), and (iv) extends the Termination Date (as defined in the Business Combination Agreement) from January 18, 2022 to January 31, 2022. In connection, and concurrently, with the execution of the Business Combination Agreement Amendment, Capstar, Capstar Sponsor Group LLC, a Delaware limited liability company (the “Sponsor”), certain affiliates of the Sponsor and Gelesis entered into an amendment (the “Sponsor Letter Agreement Amendment”) to that certain Sponsor Letter Agreement, dated July 19, 2021. Pursuant to the Sponsor Letter Agreement Amendment, the parties thereto further agreed, among other things, that (i) the vesting provisions relating to Capstar Class B Shares (as defined in the Sponsor Letter Agreement) be deleted and (ii) as of immediately prior to the Effective Time (as defined in the Sponsor Letter Agreement), 1,983,750 Capstar Class B Shares held by the Sponsor and certain affiliates of the Sponsor be surrendered to Capstar for cancellation upon such surrender, without any consideration for such surrender. The Business Combination is expected to close in the fourth quarter of 2021, following the receipt of the required approval by the Company’s stockholders and the fulfillment of other customary closing conditions.	NOTE 7. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on July 1, 2020, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of the majority of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination, subject to the terms of the underwriting agreement.

STOCKHOLDERS' DEFICIT

STOCKHOLDERS' DEFICIT	9 Months Ended	11 Months Ended
STOCKHOLDERS' DEFICIT	Sep. 30, 2021	Dec. 31, 2020
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT	NOTE 8. STOCKHOLDERS’ DEFICIT Preferred Stock Class A Common Stock Class B Common Stock outstanding Holders of Class B common stock will have the right to elect all of the Company’s directors prior to a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company).	NOTE 8. STOCKHOLDERS’ DEFICIT ( Restated, see Note 2 — Amendment 2 Preferred Stock — outstanding Class A Common Stock — issued outstanding Class B Common Stock — outstanding Holders of Class B common stock will have the right to elect all of the Company’s directors prior to a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company).

WARRANTS

WARRANTS	11 Months Ended
WARRANTS	Dec. 31, 2020
WARRANTS.
WARRANTS	NOTE 9. WARRANTS Warrants — The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and we will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 15 60 th Once the warrants become exercisable, the Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days ’ prior written notice of redemption to each warrant holder; and ● if, and only if, the reported last sale price of the Company’s Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 -trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

INCOME TAX (Restated, see Note

INCOME TAX (Restated, see Note 2)	11 Months Ended
INCOME TAX (Restated, see Note 2)	Dec. 31, 2020
INCOME TAX (Restated, see Note 2)
INCOME TAX (Restated, see Note 2)	NOTE 10. INCOME TAX (Restated, see Note 2 — Amendment 1) The Company’s net deferred tax assets are as follows: December 31, 2020 Deferred tax assets (liabilities) Net operating loss carryforward $ 36,961 Startup and organizational costs 472,542 Unrealized gain on marketable securities (43,985) Total deferred tax assets 465,518 Valuation Allowance (465,518) Deferred tax assets, net of allowance $ — The income tax provision consists of the following: For the Period from February 14, 2020 (Inception) Through December 31, 2020 Federal Current $ — Deferred (465,518) State and Local Current — Deferred — Change in valuation allowance 465,518 Income tax provision $ — As of December 31, 2020, the Company had $176,006 of U.S. federal net operating loss carryovers available to offset future taxable income. In assessing the realization of the deferred tax assets, management considers whether it is more likely than not that some portion of all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which temporary differences representing net future deductible amounts become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all of the information available, management believes that significant uncertainty exists with respect to future realization of the deferred tax assets and has therefore established a full valuation allowance. For the period from , the change in the valuation allowance was $465,518 . A reconciliation of the federal income tax rate to the Company’s effective tax rate is as follows: December 31, 2020 Statutory federal income tax rate 21.0 % Change in fair value of warrants (17.1) % Transaction costs incurred in connection with warrant liabilities (0.9) % Valuation allowance (3.0) % Income tax provision 0.0 % The Company files income tax returns in the U.S. federal jurisdiction and is subject to examination by the various taxing authorities. The Company’s tax returns since inception remain open to examination by the taxing authorities. See Note 2 for a discussion on the restatement of the Company’s financial statements.

FAIR VALUE MEASUREMENTS (Restat

FAIR VALUE MEASUREMENTS (Restated, see Note 2)	9 Months Ended	11 Months Ended
FAIR VALUE MEASUREMENTS (Restated, see Note 2)	Sep. 30, 2021	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS (Restated, see Note 2)	NOTE 10. FAIR VALUE MEASUREMENTS The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, 2021 December 31, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 276,178,675 $ 276,209,453 Liabilities: Warrant Liability – Public Warrants 1 $ 12,006,000 $ 19,458,000 Warrant Liability – Private Placement Warrants 3 $ 20,380,148 $ 10,643,808 The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed consolidated statements of operations. Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. The fair value of the Private Placement Warrants was estimated at September 30, 2021 and December 31, 2020 to be $2.71 per warrant and $1.42 per warrant, respectively, using the modified Black-Scholes option pricing model and the following assumptions: September 30, December 31, 2021 2020 Risk-free interest rate 1.02 % 0.47 % Expected Term 5.25 5.76 Dividend yield 0.00 % 0.00 % Expected volatility 13.5 % 19.0 % Exercise price $ 11.50 $ 11.50 Unit Price $ 9.92 $ 10.15 The following table presents the changes in the fair value of Level 3 warrant liabilities: Private Placement Fair value as of December 31, 2020 $ 10,643,808 Change in fair value (5,273,024) Fair value as of March 31, 2021 5,370,784 Change in fair value 1,422,600 Fair value as of June 30, 2021 6,793,384 Change in fair value 13,586,764 Fair value as of September 30, 2021 20,380,148 There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three and nine months ended September 30, 2021.	NOTE 11. FAIR VALUE MEASUREMENTS (Restated, See Note 2 — Amendment 1) The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 276,209,453 Liabilities: Warrant Liability — Public Warrants 1 19,458,000 Warrant Liability — Private Placement Warrants 3 10,643,808 The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statement of operations. Initial Measurement The Company established the initial fair value for the Warrants on July 7, 2020, the date of the Company’s Initial Public Offering, using a Monte Carlo Simulation for the Private Placement Warrants and the Public Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A common stock and one-half of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of shares of Class B common stock, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to shares of Class A common stock subject to possible redemption, shares of Class A common stock and shares of Class B common stock based on their relative fair values at the initial measurement date. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows at initial measurement: July 7, 2020 (Initial Input Measurement) Risk-free interest rate 0.39 % Tine to maturity 6.0 Dividend yield 0.00 % Expected volatility 10.0 % Exercise price $ 11.50 Unit Price $ 10.18 On July 7, 2020, the Private Placement Warrants and Public Warrants were determined to be $0.83 per warrant for aggregate values of $6.24 million and 11.45 million, respectively. Subsequent Measurement The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of December 31, 2020 is classified as Level 1 due to the use of an observable market quote in an active market. The subsequent measurement of the Private Placement Warrants was calculated using a Black Scholes Merton model which is considered a Level 3 measurement. The key inputs into the Black Scholes Merton model for the Private Placement Warrants were as follows at December 31, 2020: Input Risk-free interest rate 0.47 % Expected Term 5.76 Dividend yield 0.00 % Expected volatility 19.0 % Exercise price $ 11.50 Unit Price $ 10.15 As of December 31, 2020, the aggregate values of the Private Placement Warrants and Public Warrants were $19.46 million and $10.64 million, respectively. The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities Fair value as of January 1, 2020 $ — $ — $ — Initial measurement on July 7, 2020 (IPO) 6,241,600 11,454,000 17,695,600 Change in valuation inputs or other assumptions 4,402,208 8,004,000 12,406,208 Fair value as of December 31, 2020 $ 10,643,808 $ 19,458,000 $ 30,101,808 Due to the use of quoted prices in an active market (Level 1) to measure the fair value of the Public Warrants, subsequent to initial measurement, the Company had transfers out of Level 3 totaling approximately $11.1 million during the period from July 7, 2020 through December 31, 2020. Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. See Note 2 for a discussion on the restatement of the Company’s financial statements.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended	11 Months Ended
SUBSEQUENT EVENTS	Sep. 30, 2021	Dec. 31, 2020
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements were issued. Based upon this review, other than the below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements. As described in Note 7, the Company entered into a Business Combination Agreement on July 19, 2021 and entered into a Business Combination Agreement Amendment on November 8, 2021. In connection, and concurrently, with the execution of the Business Combination Agreement Amendment, Capstar, Capstar Sponsor Group LLC (the “Sponsor”), certain affiliates of the Sponsor and Gelesis entered into an amendment to that certain Sponsor Letter Agreement, dated July 19, 2021.	NOTE 12. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On March 3, 2021, the Sponsor committed to provide the Company an aggregate of $1,500,000 in loans for working capital purposes on an as needed basis. Such loans will be evidenced by a promissory note when issued. On July 19, 2021, we entered into a Business Combination Agreement with CPSR Gelesis Merger Sub, Inc. (“Merger Sub”) and Gelesis, Inc. (“Gelesis”) which was amended on November 8, 2021. The Business Combination Agreement and the transactions contemplated thereby were approved by the board of directors of each of CPSR and Gelesis. The Business Combination Agreement provides for, among other things, that Merger Sub will merge with and into Gelesis, with Gelesis as the surviving company in the merger and, after giving effect to such merger, Gelesis shall be our wholly-owned subsidiary (the time that the business combination becomes effective being referred to as the “Effective Time”). In addition, we will be renamed Gelesis Holdings, Inc. In accordance with the terms and subject to the conditions of the Business Combination Agreement, at the Effective Time, (i) each share of Gelesis outstanding as of immediately prior to the Effective Time will be exchanged for shares in the post-combination company (“CPSR Shares”) based on an implied Gelesis equity value of $675,000,000, (ii) all vested and unvested stock options of Gelesis will be assumed by us and thereafter be settled or exercisable for CPSR Shares, as applicable, determined based on the same implied Gelesis equity value described in clause (i); (iii) each warrant of Gelesis will be canceled in exchange for a warrant to purchase our shares of determined based on the same implied Gelesis equity value described in clause (i); and (iv) each share of CPSR Class A common stock and each share of CPSR Class B common stock that is issued and outstanding immediately prior to the Effective Time shall become one CPSR Share following the consummation of the Business Combination. In addition, each holder of shares of Gelesis common stock, options and warrants will receive its pro rata portion of 23,483,250 restricted earn out CPSR Shares, which will vest (in part) in equal thirds if the trading price of CPSR Shares is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30 -trading day period on or prior to the date that is five years following the Effective Time (the “Earn Out Period”) and will also vest in connection with any change of control transaction with respect to us if the applicable thresholds are met in such change of control transaction during the Earn Out Period. The amendment to the Business Combination Agreement extended the Termination Date (as defined in the Business Combination Agreement) from January 18, 2022 to January 31, 2022. Concurrently with the execution of the Business Combination Agreement, the Company entered into subscription agreements (the “Subscription Agreements”) with each of the PIPE Investors (as defined in the Business Combination Agreement), pursuant to which the PIPE Investors agreed to subscribe for and purchase, and the Company agreed to issue and sell to the PIPE Investors, an aggregate of 9,000,000 shares of Class A Common Stock at a price of $10.00 per share, for aggregate gross proceeds of $90 million, subject to the terms and conditions of the Subscription Agreements and the other agreements with the PIPE Investors (the “PIPE Financing”). Concurrently with the execution of the Business Combination Agreement, the Sponsor, certain affiliates of the Sponsor and Gelesis entered into the Sponsor Letter Agreement, as amended on November 8, 2021 (the “Sponsor Letter Agreement”), pursuant to which (x) such affiliates of the Sponsor have agreed to, among other things, (i) vote in favor of the Business Combination Agreement and the transactions contemplated thereby, (ii) waive any adjustment to the conversion ratio set forth in the governing documents of the Company or any other anti-dilution or similar protection with respect to the shares of Class B Common Stock (whether resulting from the transactions contemplated by the Subscription Agreements or otherwise), such that the shares of Class B Common Stock will convert into shares of the post-combination company at the closing of the business combination transaction on a one-to-one basis, (iii) be bound by certain other covenants and agreements related to the business combination and (iv) be bound by certain transfer restrictions with respect to his, her or its shares in the Company prior to the closing of the business combination, (y) the Sponsor will subject certain of the warrants to purchase Class A Common Stock currently held by it to certain vesting conditions and potential forfeiture as follows: the warrants subject to the vesting conditions and potential forfeiture (the number of which warrants will be prorated to reflect the proportionate amount of Company stockholder redemptions) will vest (and no longer be subject to forfeiture) at such time during the period from and after the closing of the business combination through and until the date that is five (5) years after the closing date (the “Sponsor Vesting Period”) (i) if the trading price of shares of the post-combination company is greater than or equal to $20.00 for any 20 trading days within any period of 30 consecutive trading days or (ii) there is a Capstar Sale (as defined in the Business Combination Agreement) in which the sale price for the acquisition of the post-combination company shares is greater than or equal to $20.00, in each case, during the Sponsor Vesting Period and (z) as of immediately prior to the Effective Time, the Sponsor will forfeit certain of its founders shares to the Company for cancellation without any consideration, in each case, on the terms and subject to the conditions set forth in the Sponsor Letter Agreement.

SUMMARY OF SIGNIFICANT ACCOUN_2

RESTATEMENT OF PREVIOUSLY ISS_2

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	11 Months Ended
	Dec. 31, 2020
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Schedule of impact of restatement on financial statements	As As As Previously Adjustments Restated Adjustments Restated Reported (Amendment 1) (Amendment 1) (Amendment 2) (Amendment 2) Balance sheet as of July 7, 2020 (unaudited) Warrant Liability $ — $ 17,695,600 $ 17,695,600 $ — $ 17,695,600 Class A Common Stock Subject to Possible Redemption 262,692,170 (17,695,600) 244,996,570 31,003,430 276,000,000 Class A Common Stock 133 177 310 (310) — Additional Paid-in Capital 5,000,179 671,724 5,671,903 (5,671,903) — Accumulated Deficit (1,000) (671,901) (672,901) (25,331,217) (26,004,118) Balance sheet as of September 30, 2020 (unaudited) Warrant Liability $ — $ 17,081,700 $ 17,081,700 $ — $ 17,081,700 Class A Common Stock Subject to Possible Redemption 262,636,479 (17,081,700) 245,554,779 30,532,860 276,087,639 Class A Common Stock 134 171 305 (305) — Additional Paid-in Capital 5,055,869 57,830 5,113,699 (5,113,699) — Accumulated Deficit (56,690) (58,001) (114,691) (25,418,856) (25,533,547) Balance sheet as of December 31, 2020 (audited) Warrant Liability $ — $ 30,101,808 $ 30,101,808 $ — 30,101,808 Class A Common Stock Subject to Possible Redemption 260,476,412 (30,101,808) 230,374,604 45,658,843 276,033,447 Common Stock 156 301 457 (457) — Additional Paid-in Capital 7,215,914 13,077,808 20,293,722 (20,293,722) — Accumulated Deficit (2,216,751) (13,078,109) (15,294,860) (25,364,664) (40,659,524) Statement of Operations for the Period from February 14, 2020 (inception) to September 30, 2020 (unaudited) Change in fair value of warrant liability $ — $ 613,900 $ 613,900 — 613,900 Transaction costs associated with Initial Public Offering — (671,901) (671,901) — (671,901) Net loss (56,690) (58,001) (114,691) — (114,691) Weighted average shares outstanding, Common stock subject to possible redemption 26,269,217 (1,769,560) 24,499,657 (24,499,657) — Basic and diluted net income per share, Common stock subject to possible redemption 0.00 — 0.00 — — Weighted average shares outstanding, Non-redeemable common stock 6,869,801 689,966 7,559,767 (7,559,767) — Basic and diluted net loss per share, Non-redeemable common stock (0.02) — (0.02) 0.02 — Weighted average shares outstanding of Class A common stock — — — 10,761,468 10,761,468 Basic and diluted net loss per share, Class A common stock — — — (0.01) (0.01) Weighted average shares outstanding of Class B common stock — — — 6,350,917 6,350,917 Basic and diluted net loss per share, Class B common stock — — — (0.01) (0.01) Statement of Operations for the Period from February 14, 2020 (inception) to December 31, 2020 (audited) Change in fair value of warrant liability $ — $ (12,406,208) $ (12,406,208) — (12,406,208) Transaction costs associated with Initial Public Offering — (671,901) (671,901) — (671,901) Net loss (2,216,751) (13,078,109) (15,294,860) — (15,294,860) Weighted average shares outstanding, Common stock subject to possible redemption 26,261,989 (1,737,369) 24,524,620 (24,524,620) — Basic and diluted net income per share, Common stock subject to possible redemption 0.00 — 0.00 — — Weighted average shares outstanding, Common stock 7,273,705 1,010,362 8,269,814 (8,269,814) — Basic and diluted net loss per share, Common stock (0.31) (1.54) (1.85) 1.85 — Weighted average shares outstanding of Class A common stock — — — 15,758,710 15,758,710 Basic and diluted net loss per share, Class A common stock — — — (0.69) (0.69) Weighted average shares outstanding of Class B common stock — — — 6,513,871 6,513,871 Basic and diluted net loss per share, Class B common stock — — — (0.69) (0.69) Basic and diluted net loss per share, Class B common stock — — — (0.69) (0.69) Statement of Changes in Stockholders’ Equity (Deficit) for the Period from February 14, 2020 (inception) to September 30, 2020 (audited) Sales of 27,600,000 Units, net of underwriting discounts 249,366,073 — — (249,366,073) — Class A common stock subject to possible redemption (245,554,775) — — 245,554,775 — Accretion for Class A common stock subject to redemption amount — — — (26,721,566) (26,721,566) Total stockholders’ equity (deficit) 5,000,003 — — (30,532,860) (25,532,857) Statement of Changes in Stockholders’ Equity (Deficit) for the Period from February 14, 2020 (inception) to December 31, 2020 (audited) Sales of 27,600,000 Units, net of underwriting discounts 249,366,073 — — (249,366,073) — Class A common stock subject to possible redemption (230,374,604) — — (230,374,604) — Accretion for Class A common stock subject to redemption amount — — — (26,721,566) (26,721,566) Total stockholders’ equity (deficit) 5,000,009 — — (45,658,843) (46,658,834) Cash Flow Statement for the Period from February 14, 2020 (inception) to September 30, 2020 (unaudited) Net loss (56,690) (58,001) (114,691) — (114,691) Change in fair value of warrant liability $ — $ (613,900) $ (613,900) — (613,900) Transaction costs associated with Initial Public Offering — 671,901 671,901 — 671,901 Initial classification of Class A common stock subject to possible redemption 262,692,170 (17,695,600) 244,996,570 31,003,430 276,000,000 Change in value of Class A common stock subject to possible redemption (55,691) 613,900 558,209 (470,570) 87,639 Cash Flow Statement for the Period from February 14, 2020 (inception) to December 31, 2020 (audited) Net loss (2,216,751) (13,078,109) (15,294,860) — (15,294,860) Change in fair value of warrant liability $ — $ (12,406,208) $ (12,406,208) — (12,406,208) Transaction costs associated with Initial Public Offering — (671,901) (671,901) — (671,901) Initial classification of Class A common stock subject to possible redemption 262,692,170 (17,695,600) 244,996,570 31,003,430 276,000,000 Change in value of Class A common stock subject to possible redemption (2,215,758) (12,406,208) (14,621,966) 14,655,413 33,447

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended	11 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Sep. 30, 2021	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of calculation of basic and diluted net income (loss) per common share	The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Period from Three Months Ended Nine Months Ended Three Months Ended February 14, September 30, September 30, September 30, 2020 (Inception) Through 2021 2021 2020 September 30, 2020 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per common share Numerator: Allocation of net income (loss), as adjusted $ (11,404,326) $ (2,851,082) $ (2,925,918) $ (731,480) $ (89,850) $ (23,841) $ (72,126) $ (42,565) Denominator: Basic and diluted weighted average stock outstanding 27,600,000 6,900,000 27,600,000 6,900,000 25,780,220 6,840,659 10,761,468 6,350,917 Basic and diluted net income (loss) per common share $ (0.41) $ (0.41) $ (0.11) $ (0.11) $ (0.00) $ (0.00) $ (0.01) $ (0.01)	For the Period from February 14, 2020 (Inception) Through December 31, 2020 Class A Common Stock Subject to Possible Redemption Numerator: Earnings allocable to Class A common stock subject to possible redemption Interest earned on marketable securities held in Trust Account $ 174,810 Less: interest available to be withdrawn for payment of taxes (146,895) Less: interest available to be withdrawn for working capital — Net income attributable to Class A common stock subject to possible redemption $ 27,915 Denominator: Weighted Average Class A common stock subject to possible redemption Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 24,524,620 Basic and diluted net income per share, Class A common stock subject to possible redemption $ 0.00 Non-Redeemable Common Stock Numerator: Net Loss minus Net Earnings Net loss $ (15,294,860) Net income allocable to Class A common stock subject to possible redemption (27,915) Non-Redeemable Net Loss $ (15,322,775) Denominator: Weighted Average Non-redeemable common Stock Basic and diluted weighted average shares outstanding, Non-redeemable common stock 8,269,814 Basic and diluted net loss per share, Non-redeemable common stock $ (1.85) For the Period from February 14, 2020 (inception) Through December 31, 2020 Class A Class B Basic and diluted net loss per common share Numerator: Allocation of net loss, as adjusted (10,821,703) (4,473,157) Denominator: — Basic and diluted weighted average stock outstanding 15,758,710 6,513,871 Basic and diluted net loss per common share (0.69) (0.69)
Summary of reconciliation of ordinary shares reflected in the condensed consolidated balance sheets		At December 31, 2020, the common stock reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 276,000,000 Less: Proceeds allocated to Public Warrants (11,454,000) Class A common stock issuance costs (15,179,927) Plus: Accretion of carrying value to redemption value 26,667,374 Class A common stock subject to possible redemption, 12/31/20 276,033,447

INCOME TAX (Restated, see Not_2

INCOME TAX (Restated, see Note 2) (Tables)	11 Months Ended
INCOME TAX (Restated, see Note 2) (Tables)	Dec. 31, 2020
INCOME TAX (Restated, see Note 2)
Schedule of Company's net deferred tax assets	December 31, 2020 Deferred tax assets (liabilities) Net operating loss carryforward $ 36,961 Startup and organizational costs 472,542 Unrealized gain on marketable securities (43,985) Total deferred tax assets 465,518 Valuation Allowance (465,518) Deferred tax assets, net of allowance $ —
Schedule of income tax provision	For the Period from February 14, 2020 (Inception) Through December 31, 2020 Federal Current $ — Deferred (465,518) State and Local Current — Deferred — Change in valuation allowance 465,518 Income tax provision $ —
Schedule of reconciliation of the federal income tax rate to the Company's effective tax rate	December 31, 2020 Statutory federal income tax rate 21.0 % Change in fair value of warrants (17.1) % Transaction costs incurred in connection with warrant liabilities (0.9) % Valuation allowance (3.0) % Income tax provision 0.0 %

FAIR VALUE MEASUREMENTS (Rest_2

FAIR VALUE MEASUREMENTS (Restated, see Note 2) (Tables)	9 Months Ended	11 Months Ended
FAIR VALUE MEASUREMENTS (Restated, see Note 2) (Tables)	Sep. 30, 2021	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
Schedule of Company's assets that are measured at fair value on a recurring basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, 2021 December 31, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 276,178,675 $ 276,209,453 Liabilities: Warrant Liability – Public Warrants 1 $ 12,006,000 $ 19,458,000 Warrant Liability – Private Placement Warrants 3 $ 20,380,148 $ 10,643,808	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 276,209,453 Liabilities: Warrant Liability — Public Warrants 1 19,458,000 Warrant Liability — Private Placement Warrants 3 10,643,808
Schedule of quantitative information regarding Level 3 fair value measurements		July 7, 2020 (Initial Input Measurement) Risk-free interest rate 0.39 % Tine to maturity 6.0 Dividend yield 0.00 % Expected volatility 10.0 % Exercise price $ 11.50 Unit Price $ 10.18 Input Risk-free interest rate 0.47 % Expected Term 5.76 Dividend yield 0.00 % Expected volatility 19.0 % Exercise price $ 11.50 Unit Price $ 10.15
Schedule of change in the fair value of the warrant liabilities	The following table presents the changes in the fair value of Level 3 warrant liabilities: Private Placement Fair value as of December 31, 2020 $ 10,643,808 Change in fair value (5,273,024) Fair value as of March 31, 2021 5,370,784 Change in fair value 1,422,600 Fair value as of June 30, 2021 6,793,384 Change in fair value 13,586,764 Fair value as of September 30, 2021 20,380,148	Private Placement Public Warrant Liabilities Fair value as of January 1, 2020 $ — $ — $ — Initial measurement on July 7, 2020 (IPO) 6,241,600 11,454,000 17,695,600 Change in valuation inputs or other assumptions 4,402,208 8,004,000 12,406,208 Fair value as of December 31, 2020 $ 10,643,808 $ 19,458,000 $ 30,101,808

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) - USD ($)	Jul. 07, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020	Jul. 28, 2021	Mar. 03, 2021
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)				27,600,000		27,600,000
Sale of Private Placement Warrants (in shares)	7,520,000					21,320,000
Price of single warrant	$ 1
Proceeds from sale of Private Placement Warrants	$ 7,520,000			$ 7,520,000	$ 0	$ 7,520,000
Transaction Costs	15,851,828	$ 0	$ 671,901	$ 671,901	0	15,851,828
Underwriting fees	5,520,000					5,520,000
Deferred underwriting fees	9,660,000	9,660,000			$ 9,660,000	9,660,000
Other offering costs	$ 671,828					$ 671,828
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account					80.00%	80.00%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination					50.00%	50.00%
Minimum net tangible assets upon consummation of the Business Combination		5,000,001			$ 5,000,001	$ 5,000,001
Threshold percentage of Public Shares subject to redemption without the Company's prior written consent					15.00%	15.00%
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)					100.00%	100.00%
Threshold business days for redemption of public shares					10 days	10 days
Maximum net interest to pay dissolution expenses					$ 100,000	$ 100,000
Cash		304,944			304,944	491,827
Operating bank accounts		276,178,675			276,178,675	276,209,453
Working capital deficit		2,265,312			2,265,312	897,026
Franchise tax payable		$ 150,000			$ 150,000	176,006
Amount on deposit in Trust Account						$ 209,000
Loans for working capital purpose							$ 4,000,000
Subsequent Event
Subsidiary, Sale of Stock [Line Items]
Loans for working capital purpose								$ 1,500,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)	27,600,000				27,600,000	27,600,000
Unit price	$ 10					$ 10
Proceeds from issuance of units	$ 276,000,000
Amount on deposit in Trust Account	$ 276,000,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares)	7,520,000					7,520,000
Price of single warrant	$ 1					$ 1
Proceeds from sale of Private Placement Warrants	$ 7,520,000					$ 7,520,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)	3,600,000				3,600,000	3,600,000
Unit price	$ 10

RESTATEMENT OF PREVIOUSLY ISS_3

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Schedule of impact of restatement on financial statements (Details) - USD ($)	2 Months Ended		3 Months Ended						6 Months Ended	8 Months Ended	9 Months Ended	11 Months Ended
	Mar. 31, 2020	Mar. 31, 2020	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Jun. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020	Jul. 07, 2020	Feb. 14, 2020	Feb. 13, 2020
CONDENSED BALANCE SHEET
Warrant liability			$ 32,386,148			$ 30,101,808	$ 17,081,700			$ 17,081,700	$ 32,386,148	$ 30,101,808	$ 17,695,600
Class A Common Stock Subject to Possible Redemption			276,028,675			276,033,447	276,087,639			276,087,639	276,028,675	276,033,447	276,000,000
Additional Paid-in Capital			0			0					0	0
Accumulated Deficit			(44,312,150)			(40,659,524)	(25,533,547)			(25,533,547)	(44,312,150)	(40,659,524)	(26,004,118)
Total stockholders' equity (deficit)	$ 24,000	$ 24,000	(44,311,460)	$ (30,073,974)	$ (26,026,715)	(40,658,834)	(25,532,857)	$ 24,000	$ (30,073,974)	(25,532,857)	(44,311,460)	(40,658,834)		$ 0	$ 0
CONDENSED STATEMENTS OF OPERATIONS
Change in fair value of warrant liability										613,900		(12,406,208)
Transaction costs associated with Initial Public Offering										(671,901)		(671,901)
Net loss	(1,000)	(1,000)	(14,255,408)	(4,088,974)	14,686,984	(15,180,169)	(113,691)	0		(114,691)	(3,657,398)	$ (15,294,860)
Weighted average shares outstanding, Common stock subject to possible redemption												24,524,620
Basic and diluted net income per share, Common stock subject to possible redemption												$ 0
Basic and diluted weighted average shares outstanding, Class B common stock												8,269,814
Basic and diluted net income per share, Class B common stock												$ (1.85)
CONDENSED STATEMENT OF CASH FLOWS
Net loss										(114,691)	(3,657,398)	$ (15,294,860)
Change in fair value of warrant liability			(13,174,144)				613,900			613,900	(2,284,340)	(12,406,208)
Transaction costs incurred in connection with warrant liability										671,901		(671,901)
Initial classification of Class A common stock subject to possible redemption										276,000,000	0	276,000,000
Change in value of Class A common stock subject to possible redemption										87,639	(4,772)	33,447
Minimum Net Tangible Assets Upon Redemption Of Temporary Equity												5,000,001
Accretion for Class A common stock subject to redemption amount										(26,721,566)		(26,721,566)
Total stockholders' equity (deficit)	$ 24,000	$ 24,000	(44,311,460)	(30,073,974)	(26,026,715)	(40,658,834)	(25,532,857)	$ 24,000	(30,073,974)	(25,532,857)	(44,311,460)	(40,658,834)		$ 0	$ 0
As Previously Reported
CONDENSED BALANCE SHEET
Class A Common Stock Subject to Possible Redemption						260,476,412	262,636,479			262,636,479		260,476,412	262,692,170
Class A common stock						156	134			134		156	133
Additional Paid-in Capital						7,215,914	5,055,869			5,055,869		7,215,914	5,000,179
Accumulated Deficit						(2,216,751)	(56,690)			(56,690)		(2,216,751)	(1,000)
Total stockholders' equity (deficit)						5,000,009	5,000,003			5,000,003		5,000,009
CONDENSED STATEMENTS OF OPERATIONS
Net loss										$ (56,690)		$ (2,216,751)
Weighted average shares outstanding, Common stock subject to possible redemption										26,269,217		26,261,989
Basic and diluted net income per share, Common stock subject to possible redemption										$ 0		$ 0
Basic and diluted weighted average shares outstanding, Class B common stock										6,869,801		7,273,705
Basic and diluted net income per share, Class B common stock										$ (0.02)		$ (0.31)
CONDENSED STATEMENT OF CASH FLOWS
Net loss										$ (56,690)		$ (2,216,751)
Initial classification of Class A common stock subject to possible redemption										262,692,170		262,692,170
Change in value of Class A common stock subject to possible redemption										(55,691)		(2,215,758)
Sale of 27,600,000 Units, net of underwriting discounts										249,366,073		249,366,073
Class A common stock subject to possible redemption										(245,554,775)		(230,374,604)
Total stockholders' equity (deficit)						5,000,009	5,000,003			5,000,003		5,000,009
Revision of Prior Period, Adjustment [Member]
CONDENSED BALANCE SHEET
Warrant liability						30,101,808	17,081,700			17,081,700		30,101,808	17,695,600
Class A Common Stock Subject to Possible Redemption						(30,101,808)	(17,081,700)			(17,081,700)		(30,101,808)	(17,695,600)
Class A common stock						301	171			171		301	177
Additional Paid-in Capital						13,077,808	57,830			57,830		13,077,808	671,724
Accumulated Deficit						(13,078,109)	$ (58,001)			(58,001)		(13,078,109)	(671,901)
CONDENSED STATEMENTS OF OPERATIONS
Change in fair value of warrant liability										613,900		(12,406,208)
Transaction costs associated with Initial Public Offering										(671,901)		(671,901)
Net loss										$ (58,001)		$ (13,078,109)
Weighted average shares outstanding, Common stock subject to possible redemption										(1,769,560)		(1,737,369)
Basic and diluted weighted average shares outstanding, Class B common stock										689,966		1,010,362
Basic and diluted net income per share, Class B common stock												$ (1.54)
CONDENSED STATEMENT OF CASH FLOWS
Net loss										$ (58,001)		$ (13,078,109)
Change in fair value of warrant liability										613,900		(12,406,208)
Transaction costs incurred in connection with warrant liability										671,901		(671,901)
Initial classification of Class A common stock subject to possible redemption										(17,695,600)		(17,695,600)
Change in value of Class A common stock subject to possible redemption										$ 613,900		(12,406,208)
Class A common stock
CONDENSED BALANCE SHEET
Class A common stock			$ 0			0					$ 0	$ 0
CONDENSED STATEMENTS OF OPERATIONS
Weighted average shares outstanding, Common stock subject to possible redemption												15,758,710
Basic and diluted net income per share, Common stock subject to possible redemption												$ (0.69)
Basic and diluted weighted average shares outstanding, Class B common stock			27,600,000				25,780,220			10,761,468	27,600,000	15,758,710
Basic and diluted net income per share, Class B common stock			$ (0.41)				$ 0			$ (0.01)	$ (0.11)	$ (0.69)
Class B common stock
CONDENSED BALANCE SHEET
Class A common stock			$ 690			690					$ 690	$ 690
CONDENSED STATEMENTS OF OPERATIONS
Basic and diluted weighted average shares outstanding, Class B common stock			6,900,000				6,840,659			6,350,917	6,900,000	6,513,871
Basic and diluted net income per share, Class B common stock			$ (0.41)				$ 0			$ (0.01)	$ (0.11)	$ (0.69)
As Restated
CONDENSED BALANCE SHEET
Warrant liability						30,101,808	$ 17,081,700			$ 17,081,700		$ 30,101,808	17,695,600
Class A Common Stock Subject to Possible Redemption						230,374,604	245,554,779			245,554,779		230,374,604	244,996,570
Class A common stock						457	305			305		457	310
Additional Paid-in Capital						20,293,722	5,113,699			5,113,699		20,293,722	5,671,903
Accumulated Deficit						(15,294,860)	(114,691)			(114,691)		(15,294,860)	(672,901)
CONDENSED STATEMENTS OF OPERATIONS
Change in fair value of warrant liability										613,900		(12,406,208)
Transaction costs associated with Initial Public Offering										(671,901)		(671,901)
Net loss										$ (114,691)		$ (15,294,860)
Weighted average shares outstanding, Common stock subject to possible redemption										24,499,657		24,524,620
Basic and diluted net income per share, Common stock subject to possible redemption										$ 0		$ 0
Basic and diluted weighted average shares outstanding, Class B common stock										7,559,767		8,269,814
Basic and diluted net income per share, Class B common stock										$ (0.02)		$ (1.85)
CONDENSED STATEMENT OF CASH FLOWS
Net loss										$ (114,691)		$ (15,294,860)
Change in fair value of warrant liability										613,900		(12,406,208)
Transaction costs incurred in connection with warrant liability										671,901		(671,901)
Initial classification of Class A common stock subject to possible redemption										244,996,570		244,996,570
Change in value of Class A common stock subject to possible redemption										558,209		(14,621,966)
As Restated
CONDENSED BALANCE SHEET
Class A Common Stock Subject to Possible Redemption				276,046,597	276,088,312	276,033,447	276,087,639		276,046,597	276,087,639		276,033,447	276,000,000
Accumulated Deficit				(30,074,664)	(26,027,405)	(40,659,524)	(25,533,547)		(30,074,664)	(25,533,547)		(40,659,524)	(26,004,118)
Total stockholders' equity (deficit)				(30,073,974)	(26,026,715)	(40,658,834)	(25,532,857)		(30,073,974)	(25,532,857)		(40,658,834)	(26,003,428)
CONDENSED STATEMENT OF CASH FLOWS
Minimum Net Tangible Assets Upon Redemption Of Temporary Equity											$ 5,000,001
Class A common stock subject to possible redemption				(30,073,974)	(26,026,715)					(25,532,857)		(40,658,834)
Accretion for Class A common stock subject to redemption amount				41,715	(54,865)
Total stockholders' equity (deficit)				$ (30,073,974)	$ (26,026,715)	(40,658,834)	(25,532,857)		$ (30,073,974)	(25,532,857)		(40,658,834)	(26,003,428)
As Restated \| Revision of Prior Period, Adjustment [Member]
CONDENSED BALANCE SHEET
Class A Common Stock Subject to Possible Redemption						45,658,843	30,532,860			30,532,860		45,658,843	31,003,430
Class A common stock						(457)	(305)			(305)		(457)	(310)
Additional Paid-in Capital						(20,293,722)	(5,113,699)			(5,113,699)		(20,293,722)	(5,671,903)
Accumulated Deficit						(25,364,664)	(25,418,856)			(25,418,856)		(25,364,664)	$ (25,331,217)
Total stockholders' equity (deficit)						(45,658,843)	(30,532,860)			$ (30,532,860)		$ (45,658,843)
CONDENSED STATEMENTS OF OPERATIONS
Weighted average shares outstanding, Common stock subject to possible redemption										(24,499,657)		(24,524,620)
Basic and diluted weighted average shares outstanding, Class B common stock										(7,559,767)		(8,269,814)
Basic and diluted net income per share, Class B common stock										$ 0.02		$ 1.85
CONDENSED STATEMENT OF CASH FLOWS
Initial classification of Class A common stock subject to possible redemption										$ 31,003,430		$ 31,003,430
Change in value of Class A common stock subject to possible redemption										(470,570)		14,655,413
Sale of 27,600,000 Units, net of underwriting discounts										(249,366,073)		(249,366,073)
Class A common stock subject to possible redemption										245,554,775		(230,374,604)
Accretion for Class A common stock subject to redemption amount										(26,721,566)		(26,721,566)
Total stockholders' equity (deficit)						$ (45,658,843)	$ (30,532,860)			$ (30,532,860)		$ (45,658,843)
As Restated \| Class A common stock
CONDENSED STATEMENTS OF OPERATIONS
Basic and diluted weighted average shares outstanding, Class B common stock				27,600,000	27,600,000				27,600,000	10,761,468		15,758,710
Basic and diluted net income per share, Class B common stock					$ 0.43				$ 0.31	$ (0.01)		$ (0.69)
As Restated \| Class A common stock \| Revision of Prior Period, Adjustment [Member]
CONDENSED STATEMENTS OF OPERATIONS
Basic and diluted weighted average shares outstanding, Class B common stock										10,761,468		15,758,710
Basic and diluted net income per share, Class B common stock										$ (0.01)		$ (0.69)
As Restated \| Class B common stock
CONDENSED STATEMENTS OF OPERATIONS
Basic and diluted weighted average shares outstanding, Class B common stock				6,900,000	6,900,000				6,900,000	6,350,917		6,513,871
Basic and diluted net income per share, Class B common stock				$ (0.59)	$ 0.43				$ 0.31	$ (0.01)		$ (0.69)
As Restated \| Class B common stock \| Revision of Prior Period, Adjustment [Member]
CONDENSED STATEMENTS OF OPERATIONS
Basic and diluted weighted average shares outstanding, Class B common stock										6,350,917		6,513,871
Basic and diluted net income per share, Class B common stock										$ (0.01)		$ (0.69)

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	9 Months Ended	11 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Jul. 07, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash equivalents	$ 0	$ 0
Unrecognized tax benefits	0	0
Unrecognized tax benefits accrued for interest and penalties	$ 0	$ 0
Anti-dilutive securities attributable to warrants (in shares)	21,320,000	21,320,000
Cash, FDIC Insured Amount	$ 250,000	$ 250,000
Class of Warrant or Right, Number of Securities Called by Warrants or Rights		21,320,000	7,520,000

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Reconciliation of Condensed Consolidated Balance Sheets (Details) - USD ($)	9 Months Ended	11 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2020	Sep. 30, 2020	Jul. 07, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Gross proceeds		$ 276,000,000
Proceeds allocated to Public Warrants		(11,454,000)	$ 11,454,000
Class A common stock issuance costs		(15,179,927)	(15,179,714)
Accretion of carrying value to redemption value	$ 4,772	26,667,374	26,667,374
Class A Common Stock Subject to Possible Redemption	$ 276,028,675	$ 276,033,447	$ 276,033,447	$ 276,087,639	$ 276,000,000

SUMMARY OF SIGNIFICANT ACCOUN_6

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Reconciliation of Net Loss per Common Share (Details) - USD ($)	2 Months Ended		3 Months Ended						8 Months Ended	9 Months Ended	11 Months Ended
	Mar. 31, 2020	Mar. 31, 2020	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Numerator: Earnings allocable to Class A common stock subject to possible redemption
Interest earned on marketable securities held in trust account											$ 174,810
Less: interest available to be withdrawn for payment of taxes											(146,895)
Net income attributable to Class A common stock subject to possible redemption											$ 27,915
Denominator: Weighted Average Class A common stock subject to possible redemption
Weighted average shares outstanding, Common stock subject to possible redemption											24,524,620
Basic and diluted net income per share, Common stock subject to possible redemption											$ 0
Numerator: Net Loss minus Net Earnings
Net loss	$ (1,000)	$ (1,000)	$ (14,255,408)	$ (4,088,974)	$ 14,686,984	$ (15,180,169)	$ (113,691)	$ 0	$ (114,691)	$ (3,657,398)	$ (15,294,860)
Net income allocable to Class A common stock subject to possible redemption											(27,915)
Non-Redeemable Net Loss											$ (15,322,775)
Denominator: Weighted Average Non-redeemable common Stock
Basic and diluted weighted average shares outstanding, Class B common stock											8,269,814
Basic and diluted net income per share, Class B common stock											$ (1.85)

SUMMARY OF SIGNIFICANT ACCOUN_7

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Calculation of Basic and Diluted Net Income (Loss) Per Common Share (Details) - USD ($)	3 Months Ended		8 Months Ended	9 Months Ended	11 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Denominator:
Basic and diluted weighted average shares outstanding (in shares)					8,269,814
Basic and diluted net income (loss) per share (in dollars per share)					$ (1.85)
Class A common stock
Basic and diluted net loss per common share : Numerator
Allocation of net loss, as adjusted					$ (10,821,703)
Denominator:
Basic and diluted weighted average shares outstanding (in shares)	27,600,000	25,780,220	10,761,468	27,600,000	15,758,710
Basic and diluted net income (loss) per share (in dollars per share)	$ (0.41)	$ 0	$ (0.01)	$ (0.11)	$ (0.69)
Class B common stock
Basic and diluted net loss per common share : Numerator
Allocation of net loss, as adjusted					$ (4,473,157)
Denominator:
Basic and diluted weighted average shares outstanding (in shares)	6,900,000	6,840,659	6,350,917	6,900,000	6,513,871
Basic and diluted net income (loss) per share (in dollars per share)	$ (0.41)	$ 0	$ (0.01)	$ (0.11)	$ (0.69)
Class A Common Stock
Denominator:
Basic and diluted weighted average shares outstanding (in shares)	27,600,000	25,780,220	10,761,468	27,600,000
Basic and diluted net income (loss) per share (in dollars per share)	$ (0.41)	$ 0	$ (0.01)	$ (0.11)
Class B Common Stock
Denominator:
Basic and diluted weighted average shares outstanding (in shares)	6,900,000	6,840,659	6,350,917	6,900,000
Basic and diluted net income (loss) per share (in dollars per share)	$ (0.41)	$ 0	$ (0.01)	$ (0.11)

PUBLIC OFFERING (Details)

PUBLIC OFFERING (Details) - $ / shares	Jul. 07, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)		27,600,000		27,600,000
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)	27,600,000		27,600,000	27,600,000
Price per share			$ 10	$ 10
Number of shares in a unit			1	1
Number of warrants in a unit			0.5	0.5
Number of shares issuable per warrant			1	1
Exercise price of warrants			$ 11.50	$ 11.50
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)	3,600,000		3,600,000	3,600,000

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - USD ($)	Jul. 07, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
PRIVATE PLACEMENT.
Number of warrants to purchase shares issued	7,520,000			21,320,000
Price of warrants	$ 1
Aggregate purchase price	$ 7,520,000	$ 7,520,000	$ 0	$ 7,520,000
Number of shares per warrant	1
Exercise price of warrant	$ 11.50

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details)	Jul. 01, 2020D$ / sharesshares	Feb. 26, 2020USD ($)shares	Mar. 31, 2020USD ($)	Mar. 31, 2020USD ($)
Related Party Transaction [Line Items]
Aggregate purchase price \| $			$ 25,000	$ 25,000
Founder Shares \| Sponsor \| Class B common stock
Related Party Transaction [Line Items]
Number of shares issued		5,750,000
Aggregate purchase price \| $		$ 25,000
Share dividend	1,150,000
Aggregate number of shares owned	6,900,000
Shares subject to forfeiture	900,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders	20.00%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) \| $ / shares	$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| D	20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| D	30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences	150 days

RELATED PARTY TRANSACTIONS - Ad

RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($)	Jul. 07, 2020	Jul. 01, 2020	Feb. 14, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020	Feb. 14, 2021
Related Party Transaction [Line Items]
Repayment of promissory note - related party				$ 150,000	$ 0	$ 150,000
Administrative Support Agreement
Related Party Transaction [Line Items]
Expenses per month		$ 10,000
Expenses incurred and paid						60,000
Promissory Note with Related Party
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note			$ 250,000				$ 250,000
Repayment of promissory note - related party	$ 140,000		$ 150,000
Related Party Loans
Related Party Transaction [Line Items]
Maximum Loans Convertible Into Warrants					$ 1,500,000	$ 1,500,000
Price of warrants (in dollars per share)					$ 1	$ 1

COMMITMENTS (Details)

COMMITMENTS (Details)	Sep. 30, 2021USD ($)$ / shares	Dec. 31, 2020USD ($)$ / shares	Jul. 07, 2020USD ($)	Jul. 01, 2020item
COMMITMENTS
Maximum number of demands for registration of securities \| item				3
Deferred fee per unit \| $ / shares	$ 0.35	$ 0.35
Deferred underwriting fee payable \| $	$ 9,660,000	$ 9,660,000	$ 9,660,000

STOCKHOLDERS' DEFICIT - Preferr

STOCKHOLDERS' DEFICIT - Preferred Stock Shares (Details) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
STOCKHOLDERS' DEFICIT
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred shares, par value	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

STOCKHOLDERS' DEFICIT - Common

STOCKHOLDERS' DEFICIT - Common Stock Shares (Details)	Sep. 30, 2021$ / sharesshares	Dec. 31, 2020$ / sharesshares	Feb. 26, 2020Vote$ / sharesshares
Class of Stock [Line Items]
Class A common stock subject to possible redemption, issued (in shares)		27,600,000
Class A common stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	100,000,000	100,000,000	100,000,000
Common shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Common shares, votes per share \| Vote			1
Common shares, shares issued (in shares)	0	0
Common shares, shares outstanding (in shares)	0	0
Class A common stock subject to possible redemption, issued (in shares)		26,044,485
Class A common stock subject to possible redemption, outstanding (in shares)		27,600,000
Class B common stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	10,000,000	10,000,000	10,000,000
Common shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Common shares, votes per share \| Vote			1
Common shares, shares issued (in shares)	6,900,000	6,900,000
Common shares, shares outstanding (in shares)	6,900,000	6,900,000
Threshold conversion ratio of stock	20.00%	20.00%

Warrants (Details)

Warrants (Details) - Warrants	9 Months Ended	11 Months Ended
Warrants (Details) - Warrants	Sep. 30, 2021D$ / shares	Dec. 31, 2020Ditem$ / shares
Class of Warrant or Right [Line Items]
Public Warrants exercisable term after the completion of a business combination	30 days	30 days
Public Warrants exercisable term from the closing of the initial public offering	12 months	12 months
Public Warrants expiration term	5 years	5 years
Threshold period for filling registration statement after business combination	15 days	15 days
Threshold period for registration statement to be effective after which warrants can be exercised on a cashless basis	60 days	60 days
Threshold issue price for capital raising purposes in connection with the closing of a Business Combination	$ 9.20	$ 9.20
Percentage of gross proceeds on total equity proceeds	60.00%	60.00%
Threshold trading days for calculating Market Value	20	20
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115.00%	115.00%
Adjustment two of redemption price of stock based on market value and newly issued price (as a percent)	180.00%	180.00%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days	30 days
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18	$ 18
Redemption price per public warrant (in dollars per share)	$ 0.01	$ 0.01
Minimum threshold written notice period for redemption of public warrants		30 days
Threshold trading days for redemption of public warrants \| D	20	20
Threshold number of business days before sending notice of redemption to warrant holders	3	3
Redemption period	30 days	30 days

INCOME TAX (Restated, see Not_3

INCOME TAX (Restated, see Note 2) - Net deferred tax assets (Details)	Dec. 31, 2020USD ($)
Deferred tax assets (liabilities)
Net operating loss carryforward	$ 36,961
Startup and organizational costs	472,542
Unrealized gain on marketable securities	(43,985)
Total deferred tax assets	465,518
Valuation Allowance	$ (465,518)

INCOME TAX (Restated, see Not_4

INCOME TAX (Restated, see Note 2) - Income tax provision (Details) - USD ($)	3 Months Ended		8 Months Ended	9 Months Ended	11 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Federal
Deferred					$ (465,518)
Change in valuation allowance					$ 465,518
Income tax provision	$ 0	$ 8,714	$ 8,714	$ 0

INCOME TAX (Restated, see Not_5

INCOME TAX (Restated, see Note 2) - Additional Information (Details)	11 Months Ended
	Dec. 31, 2020USD ($)
INCOME TAX (Restated, see Note 2)
U.S. federal net operating loss carryovers	$ 176,006
Change in valuation allowance	$ 465,518

INCOME TAX (Restated, see Not_6

INCOME TAX (Restated, see Note 2) - Reconciliation of federal income tax rate (Details)	11 Months Ended
	Dec. 31, 2020
INCOME TAX (Restated, see Note 2)
Statutory federal income tax rate	21.00%
Change in fair value of warrants	(17.10%)
Transaction costs incurred in connection with warrant liabilities	(0.90%)
Valuation allowance	(3.00%)
Income tax provision	0.00%

FAIR VALUE MEASUREMENTS (Rest_3

FAIR VALUE MEASUREMENTS (Restated, see Note 2) (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jul. 07, 2020
Liabilities:
Warrant liability	$ 32,386,148	$ 30,101,808	$ 17,081,700	$ 17,695,600
Level 1 \| Recurring
Assets:
Cash and marketable securities held in Trust Account	276,178,675	276,209,453
Level 1 \| Recurring \| Public Warrants
Liabilities:
Warrant liability	12,006,000	19,458,000
Level 3 \| Recurring \| Private Placement Warrants
Liabilities:
Warrant liability	$ 20,380,148	$ 10,643,808

FAIR VALUE MEASUREMENTS (Rest_4

FAIR VALUE MEASUREMENTS (Restated, see Note 2) - Initial Measurement and Subsequent Measurement (Details)	Jul. 07, 2020USD ($)Y$ / shares	Dec. 31, 2020USD ($)item$ / sharesY	Sep. 30, 2021item
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate values		$ 17,695,600
Exercise price of warrant \| $ / shares	$ 11.50
Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate values		11,454,000
Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate values		$ 6,241,600
Risk-free interest rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input \| item		0.47	1.02
Risk-free interest rate \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	0.39
Tine to maturity \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input \| Y	6
Dividend yield
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input \| item		0	0
Dividend yield \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	0
Expected volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input \| item		19	13.5
Expected volatility \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input	10
Exercise price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input \| item		11.50	11.50
Exercise price \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input \| $ / shares	11.50
Unit Price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input \| item		10.15	9.92
Monte Carlo simulation model \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Exercise price of warrant \| $ / shares	$ 0.83
Monte Carlo simulation model \| Level 3 \| Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate values	$ 11,450,000
Monte Carlo simulation model \| Level 3 \| Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate values	$ 6,240,000
Monte Carlo simulation model \| Unit Price \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input \| $ / shares	10.18
Black Scholes Merton model \| Level 3 \| Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate values		$ 19,460,000
Black Scholes Merton model \| Level 3 \| Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Aggregate values		$ 10,640,000
Black Scholes Merton model \| Risk-free interest rate \| Level 3 \| Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input		0.47
Black Scholes Merton model \| Tine to maturity \| Level 3 \| Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input \| Y		5.76
Black Scholes Merton model \| Dividend yield \| Level 3 \| Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input		0
Black Scholes Merton model \| Expected volatility \| Level 3 \| Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input		19
Black Scholes Merton model \| Exercise price \| Level 3 \| Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input \| $ / shares		11.50
Black Scholes Merton model \| Unit Price \| Level 3 \| Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Measurement Input \| $ / shares		10.15

FAIR VALUE MEASUREMENTS (Rest_5

FAIR VALUE MEASUREMENTS (Restated, see Note 2) - Changes in the fair value of warrant liabilities (Details) - USD ($)	3 Months Ended			6 Months Ended	11 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value as of beginning			$ 30,101,808
Initial measurement on July 7, 2020 (IPO)					$ 17,695,600
Change in valuation inputs or other assumptions					12,406,208
Fair value as of ending				$ 30,101,808	30,101,808
Transfers of public warrant to Level 3				11,100,000
Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value as of beginning			19,458,000
Initial measurement on July 7, 2020 (IPO)					11,454,000
Change in valuation inputs or other assumptions					8,004,000
Fair value as of ending				19,458,000	19,458,000
Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value as of beginning	$ 6,793,384	$ 5,370,784	10,643,808
Initial measurement on July 7, 2020 (IPO)					6,241,600
Change in valuation inputs or other assumptions	13,586,764	1,422,600	(5,273,024)		4,402,208
Fair value as of ending	$ 20,380,148	$ 6,793,384	$ 5,370,784	$ 10,643,808	$ 10,643,808

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	Jul. 19, 2021	Jul. 28, 2021	Mar. 03, 2021
Subsequent Event [Line Items]
Loans for working capital purpose		$ 4,000,000
Subsequent Event
Subsequent Event [Line Items]
Loans for working capital purpose			$ 1,500,000
Trading price for future vesting threshold of the first third	$ 20
Trading price for future vesting threshold of the second third	$ 20
Stock Issued During Period, Value, Other	$ 90,000,000
Stock Issued During Period, Shares, Other	9,000,000
Shares Issued, Price Per Share	$ 10
Subsequent Event \| CPSR, CPSR Gelesis Merger Sub, Inc.
Subsequent Event [Line Items]
Implied equity value	$ 675,000,000
Number of pro rata portion of restricted earn out CPSR shares will be received by each holder of common stock, options and warrants	23,483,250
Trading price for future vesting threshold of the first third	$ 12.50
Trading price for future vesting threshold of the second third	15
Trading price for future vesting threshold of the third portion	$ 17.50
Number of trading days within specified period that share price must exceed	20 days
Consecutive trading days used to evaluate share price	30 days

CONDENSED BALANCE SHEET

CONDENSED BALANCE SHEET - USD ($)	Sep. 30, 2021	Dec. 31, 2020
Current assets
Cash	$ 304,944	$ 491,827
Prepaid expenses	39,816	65,973
Total Current Assets	344,760	557,800
Cash and marketable securities held in Trust Account	276,178,675	276,209,453
Total Assets	276,523,435	276,767,253
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities - Accrued expenses		1,630,832
Current liabilities - Accounts payable and accrued expenses	2,760,072	1,630,832
Warrant liabilities	32,386,148	30,101,808
Deferred underwriting fee payable	9,660,000	9,660,000
Total Liabilities	44,806,220	41,392,640
Commitments
Class A common stock subject to possible redemption 27,600,000 shares at redemption value as of September 30, 2021 and December 31, 2020	276,028,675	276,033,447
Stockholders' Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding	0	0
Additional paid-in capital	0	0
Accumulated deficit	(44,312,150)	(40,659,524)
Total Stockholders' Deficit	(44,311,460)	(40,658,834)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	276,523,435	276,767,253
Class A common stock
Stockholders' Deficit
Common stock	0	0
Class B common stock
Stockholders' Deficit
Common stock	$ 690	$ 690

CONDENSED BALANCE SHEET (Parent

CONDENSED BALANCE SHEET (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020	Feb. 26, 2020
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A common stock
Ordinary shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	100,000,000	100,000,000	100,000,000
Ordinary shares, shares issued	0	0
Ordinary shares, shares outstanding	0	0
Temporary Equity, Shares Outstanding		27,600,000
Class A common stock subject to possible redemption
Ordinary shares, shares issued	27,600,000	27,600,000
Ordinary shares, shares outstanding	27,600,000	27,600,000
Temporary Equity, Shares Outstanding	27,600,000	27,600,000
Class B common stock
Ordinary shares, par value	$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized	10,000,000	10,000,000	10,000,000
Ordinary shares, shares issued	6,900,000	6,900,000
Ordinary shares, shares outstanding	6,900,000	6,900,000

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		8 Months Ended	9 Months Ended
CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2021
General and administrative expenses	$ 1,113,342	$ 184,615	$ 185,615	$ 1,518,286
Loss from operations	(1,113,342)	(184,615)	(185,615)	(1,518,286)
Other income (expense):
Interest earned on marketable securities held in Trust Account	138,117	96,143	96,143	142,997
Unrealized gain (loss) on marketable securities held in Trust Account	(106,039)	41,496	41,496	2,231
Change in fair value of warrant liabilities	(13,174,144)	613,900	613,900	(2,284,340)
Transaction costs associated with the Initial Public Offering	0	(671,901)	(671,901)	0
Total other income (expense), net	(13,142,066)	79,638	79,638	(2,139,112)
Loss before income taxes	(14,255,408)	(104,977)	(105,977)	(3,657,398)
Provision for income taxes	0	(8,714)	(8,714)	0
Net loss	$ (14,255,408)	$ (113,691)	$ (114,691)	$ (3,657,398)
Class A common stock
Other income (expense):
Basic and diluted weighted average shares outstanding (in shares)	27,600,000	25,780,220	10,761,468	27,600,000
Basic and diluted net income (loss) per share (in dollars per share)	$ (0.41)	$ 0	$ (0.01)	$ (0.11)
Class B common stock
Other income (expense):
Basic and diluted weighted average shares outstanding (in shares)	6,900,000	6,840,659	6,350,917	6,900,000
Basic and diluted net income (loss) per share (in dollars per share)	$ (0.41)	$ 0	$ (0.01)	$ (0.11)

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Class A common stockCommon Stock	Class A common stock subject to possible redemptionCommon Stock	Class B common stockCommon Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at the beginning at Feb. 13, 2020	$ 0		$ 0	$ 0	$ 0	$ 0
Balance at the beginning (in shares) at Feb. 13, 2020	0		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B common stock to Sponsor			$ 690	24,310		25,000
Issuance of Class B common stock to Sponsor (in shares)			6,900,000
Net income (loss)					(1,000)	(1,000)
Balance at the end at Mar. 31, 2020			$ 690	24,310	(1,000)	24,000
Balance at the end (in shares) at Mar. 31, 2020			6,900,000
Balance at the beginning at Feb. 13, 2020	$ 0		$ 0	0	0	0
Balance at the beginning (in shares) at Feb. 13, 2020	0		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)						(114,691)
Balance at the end at Sep. 30, 2020			$ 690		(25,533,547)	(25,532,857)
Balance at the end (in shares) at Sep. 30, 2020			6,900,000
Balance at the beginning at Feb. 13, 2020	$ 0		$ 0	0	0	0
Balance at the beginning (in shares) at Feb. 13, 2020	0		0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)						(15,294,860)
Balance at the end at Dec. 31, 2020			$ 690		(40,659,524)	(40,658,834)
Balance at the end (in shares) at Dec. 31, 2020			6,900,000
Balance at the beginning at Feb. 14, 2020		$ 0	$ 0	0	0	0
Balance at the beginning (in shares) at Feb. 14, 2020		0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B common stock to Sponsor			$ 690	24,310		25,000
Issuance of Class B common stock to Sponsor (in shares)			6,900,000
Net income (loss)					(1,000)	(1,000)
Balance at the end at Mar. 31, 2020			$ 690	24,310	(1,000)	24,000
Balance at the end (in shares) at Mar. 31, 2020			6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		$ 0	$ 0	0	0	0
Balance at the end at Jun. 30, 2020			$ 690	24,310	(1,000)	24,000
Balance at the end (in shares) at Jun. 30, 2020			6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A common stock to redemption amount				(1,302,710)	(25,418,856)	(26,721,566)
Excess cash received from sale of Private Placement Warrants				$ 1,278,400		1,278,400
Net income (loss)					(113,691)	(113,691)
Balance at the end at Sep. 30, 2020			$ 690		(25,533,547)	(25,532,857)
Balance at the end (in shares) at Sep. 30, 2020			6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A common stock to redemption amount					(54,192)	(54,192)
Net income (loss)					(15,180,169)	(15,180,169)
Balance at the end at Dec. 31, 2020			$ 690		(40,659,524)	(40,658,834)
Balance at the end (in shares) at Dec. 31, 2020			6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A common stock to redemption amount					(54,865)	(54,865)
Net income (loss)					14,686,984	14,686,984
Balance at the end at Mar. 31, 2021			$ 690		(26,027,405)	(26,026,715)
Balance at the end (in shares) at Mar. 31, 2021			6,900,000
Balance at the beginning at Dec. 31, 2020			$ 690		(40,659,524)	(40,658,834)
Balance at the beginning (in shares) at Dec. 31, 2020			6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)						(3,657,398)
Balance at the end at Sep. 30, 2021			$ 690		(44,312,150)	(44,311,460)
Balance at the end (in shares) at Sep. 30, 2021			6,900,000
Balance at the beginning at Mar. 31, 2021			$ 690		(26,027,405)	(26,026,715)
Balance at the beginning (in shares) at Mar. 31, 2021			6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A common stock to redemption amount					41,715	41,715
Net income (loss)					(4,088,974)	(4,088,974)
Balance at the end at Jun. 30, 2021			$ 690		(30,074,664)	(30,073,974)
Balance at the end (in shares) at Jun. 30, 2021			6,900,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accretion for Class A common stock to redemption amount					17,922	17,922
Net income (loss)					(14,255,408)	(14,255,408)
Balance at the end at Sep. 30, 2021			$ 690		$ (44,312,150)	$ (44,311,460)
Balance at the end (in shares) at Sep. 30, 2021			6,900,000

CONDENSED STATEMENT OF CASH FLO

CONDENSED STATEMENT OF CASH FLOWS - USD ($)	8 Months Ended	9 Months Ended
CONDENSED STATEMENT OF CASH FLOWS - USD ($)	Sep. 30, 2020	Sep. 30, 2021
Cash Flows from Operating Activities:
Net loss	$ (114,691)	$ (3,657,398)
Adjustments to reconcile net loss to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account	(96,143)	(142,997)
Unrealized gain on marketable securities held in Trust Account	(41,496)	(2,231)
Transaction costs associated with the Initial Public Offering	671,901	0
Change in fair value of warrant liabilities	(613,900)	2,284,340
Deferred tax provision	8,714	0
Changes in operating assets and liabilities:
Prepaid expenses	(81,365)	26,157
Accounts payable and accrued expenses	54,771	1,129,240
Net cash used in operating activities	(212,209)	(362,889)
Cash Flows from Investing Activities:
Cash withdrawn from Trust Account to pay for franchise taxes	0	176,006
Investment of cash into Trust Account	(276,000,000)	0
Net cash provided by (used in) investing activities	(276,000,000)	176,006
Cash Flows from Financing Activities:
Proceeds from issuance of Class B common stock to Sponsor	25,000	0
Proceeds from sale of Units, net of underwriting discounts paid	270,480,000	0
Proceeds from sale of Private Placement Warrants	7,520,000	0
Proceeds from promissory note - related party	150,000	0
Repayment of promissory note - related party	(150,000)	0
Payment of offering costs	(671,828)	0
Net cash provided by financing activities	277,353,172	0
Net Change in Cash	1,140,963	(186,883)
Cash - Beginning of period	0	491,827
Cash - End of period	1,140,963	304,944
Non-Cash investing and financing activities:
Initial classification of Class A common stock subject to possible redemption	276,000,000	0
Change in value of Class A common stock subject to possible redemption	87,639	(4,772)
Deferred underwriting fee payable	$ 9,660,000	$ 0

DESCRIPTION OF ORGANIZATION A_3

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	9 Months Ended	11 Months Ended
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	Sep. 30, 2021	Dec. 31, 2020
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATION S Capstar Special Purpose Acquisition Corp. (the “Company”) is a blank check company incorporated in Delaware on February 14, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the consumer, healthcare and technology, media and telecommunications (“TMT”) industries. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has one wholly-owned subsidiary, CPSR Gelesis Merger Sub, Inc., which was incorporated in the State of Delaware on July 2, 2021 (“Merger Sub”). As of September 30, 2021, the Company had not commenced any operations. All activity through September 30, 2021 relates to the Company’s formation, its initial public offering (“Initial Public Offering”), which is described below, the search for a target company for a Business Combination and activities in connection with the proposed business combination with Gelesis, Inc., a Delaware corporation (“Gelesis”) (see Note 7). The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the marketable securities held in the Trust Account. The registration statement for the Company’s Initial Public Offering was declared effective on July 1, 2020. On July 7, 2020, the Company consummated the Initial Public Offering of 27,600,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,520,000 warrants (each, a “Private Placement Warrant” and, collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Capstar Sponsor Group, LLC (the “Sponsor”), generating gross proceeds of $7,520,000, which is described in Note 5. Transaction costs amounted to $15,851,828, consisting of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees and $671,828 of other offering costs. Following the closing of the Initial Public Offering on July 7, 2020, an amount of $276,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”). The proceeds are held in the Trust Account located in the United States and shall be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the funds in the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (excluding taxes payable on interest income earned from the Trust Account and the deferred underwriting commissions) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to public stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law or stock exchange requirements and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (i) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (ii) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their shares in conjunction with any such amendment. The Company will have until July 7, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten The Sponsor has agreed to waive its right to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these condensed consolidated financial statements. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. Liquidity and Management’s Plan As of September 30, 2021, the Company had $304,944 in its operating bank accounts, $276,178,675 in securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital deficit of $2,265,312, which excludes $150,000 of franchise taxes payable. On July 28, 2021, the Sponsor committed to provide the Company an aggregate of $4,000,000 in loans for working capital purposes (see Note 6). These loans will be non-interest bearing, unsecured and will be repaid upon the consummation of a Business Combination. If the Company does not consummate a Business Combination, all amounts loaned to the Company in connection with these loans will be forgiven except to the extent that the Company has funds available to it outside of its Trust Account. As a result, management has determined that sufficient capital exists to sustain operations through the earlier of the consummation of a Business Combination or July 7, 2022, the scheduled liquidation date of the Company if a Business Combination is not completed.	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Capstar Special Purpose Acquisition Corp. (the “Company”) was incorporated in Delaware on February 14, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). Although the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company intends to focus on businesses in the consumer, healthcare and technology, media and telecommunications (“TMT”) industries. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. As of December 31, 2020, the Company had not commenced any operations. All activity for the period from February 14, 2020 (inception) through December 31, 2020 relates to the Company’s formation, its initial public offering (“Initial Public Offering”), which is described below, and the search for a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The registration statement for the Company’s Initial Public Offering was declared effective on July 1, 2020. On July 7, 2020, the Company consummated the Initial Public Offering of 27,600,000 units (the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which includes the full exercise by the underwriters of the over-allotment option to purchase an additional 3,600,000 Units, at $10.00 per Unit, generating gross proceeds of $276,000,000, which is described in Note 4. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 7,520,000 warrants (each, a “Private Placement Warrant” and, collectively, the “Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant in a private placement to Capstar Sponsor Group, LLC (the “Sponsor”), generating gross proceeds of $7,520,000, which is described in Note 5. Transaction costs amounted to $15,851,828, consisting of $5,520,000 of underwriting fees, $9,660,000 of deferred underwriting fees and $671,828 of other offering costs. Following the closing of the Initial Public Offering on July 7, 2020, an amount of $276,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”). The proceeds are held in the Trust Account located in the United States and shall be invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination or (ii) the distribution of the funds in the Trust Account, as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company’s initial Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (excluding taxes payable on interest income earned from the Trust Account and the deferred underwriting commissions) at the time of the agreement to enter into the initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to public stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 7). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law or stock exchange requirements and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Company’s Sponsor has agreed to vote its Founder Shares (as defined in Note 6) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. Notwithstanding the above, if the Company seeks stockholder approval of a Business Combination and it does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Certificate of Incorporation provides that a public stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company. The Sponsor has agreed (i) to waive its redemption rights with respect to its Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (ii) not to propose an amendment to the Company’s Amended and Restated Certificate of Incorporation that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their shares in conjunction with any such amendment. The Company will have until July 7, 2022 to consummate a Business Combination (the “Combination Period”). If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten The Sponsor has agreed to waive its right to liquidating distributions from the Trust Account with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor acquires Public Shares in or after the Initial Public Offering, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 7) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per Unit ($10.00). In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except for the Company’s auditors), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Liquidity and Management’s Plan As of December 31, 2020, the Company had $491,827 in its operating bank accounts, $276,209,453 in securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith and working capital deficit of $897,026, which excludes $176,006 of franchise taxes payable. As of December 31, 2020, approximately $209,000 of the amount on deposit in the Trust Account represented interest income, which is available to pay the Company’s tax obligations. As of December 31, 2020, the Company lacked the liquidity it needed to sustain operations for a reasonable period of time, which is considered to be one year from the issuance date of the financial statements and had substantial doubt over its ability to continue as a going concern. On March 3, 2021 (see Note 12), the Sponsor committed to provide the Company an aggregate of $1,500,000 in loans for working capital purposes. Accordingly, management has since reevaluated the Company’s liquidity and financial condition and determined that sufficient capital exists to sustain operations for at least one year from the issuance date of these financial statements and therefore substantial doubt has been alleviated.

RESTATEMENT OF PREVIOUSLY ISS_4

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	9 Months Ended
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	Sep. 30, 2021
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS	NOTE 2. RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS In connection with the preparation of the Company’s condensed consolidated financial statements as of September 30, 2021, management identified errors made in its historical financial statements where, at the closing of the Company’s Initial Public Offering, the Company improperly valued its Class A common stock subject to possible redemption. The Company previously determined the Class A common stock subject to possible redemption to be equal to the redemption value, while also taking into consideration a redemption cannot result in net tangible assets being less than $5,000,001. Management determined that the Public Shares underlying the Units issued during the Initial Public Offering can be redeemed or become redeemable subject to the occurrence of future events considered outside the Company’s control. Therefore, management concluded that temporary equity should include all shares of Class A common stock subject to possible redemption, resulting in the Class A common stock subject to possible redemption being equal to their redemption value. As a result, management has noted a classification error related to temporary equity and permanent equity. This resulted in an adjustment to the initial carrying value of the Class A common stock subject to possible redemption with the offset recorded to additional paid-in capital (to the extent available), accumulated deficit and Class A common stock. In connection with the change in presentation for the Class A common stock subject to possible redemption, the Company also restated its income (loss) per common share calculation to allocate net income (loss) evenly to Class A and Class B common stock. This presentation contemplates a Business Combination as the most likely outcome, in which case, both classes of common stock share pro rata in the income (loss) of the Company. There has been no change in the Company’s total assets, liabilities or operating results. The impact of the restatement on the Company’s condensed consolidated financial statements is reflected in the following table. As Previously Reported Adjustment As Restated Balance Sheet as of July 7, 2020 Class A common stock subject to possible redemption $ 244,996,570 $ 31,003,430 $ 276,000,000 Class A common stock $ 310 $ (310) $ — Additional paid-in capital $ 5,671,903 $ (5,671,903) $ — Accumulated deficit $ (672,901) $ (25,331,217) $ (26,004,118) Total stockholders’ equity (deficit) $ 5,000,002 $ (31,003,430) $ (26,003,428) Number of shares subject to redemption 24,499,657 3,100,343 27,600,000 Balance Sheet as of September 30, 2020 Class A common stock subject to possible redemption $ 245,554,779 $ 30,532,860 $ 276,087,639 Class A common stock $ 305 $ (305) $ — Additional paid-in capital $ 5,113,699 $ (5,113,699) $ — Accumulated deficit $ (114,691) $ (25,418,856) $ (25,533,547) Total stockholders’ equity (deficit) $ 5,000,003 $ (30,532,860) $ (25,532,857) Number of shares subject to redemption 24,547,683 3,052,317 27,600,000 Balance Sheet as of December 31, 2020 Class A common stock subject to possible redemption $ 230,374,604 $ 45,658,843 $ 276,033,447 Class A common stock $ 457 $ (457) $ — Additional paid-in capital $ 20,293,722 $ (20,293,722) $ — Accumulated deficit $ (15,294,860) $ (25,364,664) $ (40,659,524) Total stockholders’ equity (deficit) $ 5,000,009 $ (45,658,843) $ (40,658,834) Number of shares subject to redemption 23,034,669 4,565,331 27,600,000 Balance Sheet as of March 31, 2021 Class A common stock subject to possible redemption $ 245,061,587 $ 31,026,725 $ 276,088,312 Class A common stock $ 311 $ (311) $ — Additional paid-in capital $ 5,606,885 $ (5,606,885) $ — Accumulated deficit $ (607,876) $ (25,419,529) $ (26,027,405) Total stockholders’ equity (deficit) $ 5,000,010 $ (31,026,725) $ (26,026,715) Number of shares subject to redemption 24,493,884 3,106,116 27,600,000 Balance Sheet as of June 30, 2021 Class A common stock subject to possible redemption $ 240,972,620 $ 35,073,977 $ 276,046,597 Class A common stock $ 352 $ (352) $ — Additional paid-in capital $ 9,695,811 $ (9,695,811) $ — Accumulated deficit $ (4,696,850) $ (25,377,814) $ (30,074,664) Total stockholders’ equity (deficit) $ 5,000,003 $ (35,073,977) $ (30,073,974) Number of shares subject to redemption 24,084,470 3,515,530 27,600,000 Statement of Operations for the Period from February 14, 2020 (Inception) Through September 30, 2020 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 24,499,657 (24,499,657) — Basic and diluted weighted average shares outstanding, Non-redeemable common stock 7,559,767 (7,559,767) — Basic and diluted net loss per share, Non-redeemable common stock $ (0.02) $ 0.02 $ — Weighted average shares outstanding of Class A common stock — 10,761,468 10,761,468 Basic and diluted net loss per share, Class A common stock $ — $ (0.01) $ (0.01) Weighted average shares outstanding of Class B common stock — 6,350,917 6,350,917 Basic and diluted net loss per share, Class B common stock $ — $ (0.01) $ (0.01) Statement of Operations for the Period from February 14, 2020 (Inception) Through December 31, 2020 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 24,524,620 (24,524,620) — Basic and diluted weighted average shares outstanding, Non-redeemable common stock 8,269,814 (8,269,814) — Basic and diluted net loss per share, Non-redeemable common stock $ (1.85) $ 1.85 $ — Weighted average shares outstanding of Class A common stock — 15,758,710 15,758,710 Basic and diluted net loss per share, Class A common stock $ — $ (0.69) $ (0.69) Weighted average shares outstanding of Class B common stock — 6,513,871 6,513,871 Basic and diluted net loss per share, Class B common stock $ — $ (0.69) $ (0.69) Statement of Operations for the Three Months Ended March 31, 2021 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 23,034,669 (23,034,669) — Basic and diluted weighted average shares outstanding, Non-redeemable common stock 11,465,331 (11,465,331) — Basic and diluted net income per share, Non-redeemable common stock $ 1.28 $ (1.28) $ — Weighted average shares outstanding of Class A common stock — 27,600,000 27,600,000 Basic and diluted net income per share, Class A common stock $ — $ 0.43 $ 0.43 Weighted average shares outstanding of Class B common stock — 6,900,000 6,900,000 Basic and diluted net income per share, Class B common stock $ — $ 0.43 $ 0.43 As Previously Reported Adjustment As Restated Statement of Operations for the Three Months Ended June 30, 2021 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 24,493,884 (24,493,884) — Basic and diluted weighted average shares outstanding, Non-redeemable common stock 10,006,116 (10,006,116) — Basic and diluted net loss per share, Non-redeemable common stock $ (0.41) $ 0.41 $ — Weighted average shares outstanding of Class A common stock — 27,600,000 27,600,000 Basic and diluted net loss per share, Class A common stock $ — $ — $ — Weighted average shares outstanding of Class B common stock — 6,900,000 6,900,000 Basic and diluted net loss per share, Class B common stock $ — $ (0.59) $ (0.59) Statement of Operations for the Six Months Ended June 30, 2021 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 23,768,307 (23,768,307) — Basic and diluted weighted average shares outstanding, Non-redeemable common stock 10,731,693 (10,731,693) — Basic and diluted net income per share, Non-redeemable common stock $ 0.99 $ (0.99) $ — Weighted average shares outstanding of Class A common stock — 27,600,000 27,600,000 Basic and diluted net income per share, Class A common stock $ — $ 0.31 $ 0.31 Weighted average shares outstanding of Class B common stock — 6,900,000 6,900,000 Basic and diluted net income per share, Class B common stock $ — $ 0.31 $ 0.31 Statement of Changes in Shareholders’ Equity (Deficit) for the Period from February 14, 2020 (Inception) Through September 30, 2020 Sale of 27,600,000 Units, net of underwriting discounts $ 249,366,073 $ (249,366,073) $ — Class A common stock subject to possible redemption $ (245,554,775) $ 245,554,775 $ — Accretion for Class A ordinary share subject to redemption amount $ — $ (26,721,566) $ (26,721,566) Total shareholders’ equity (deficit) $ 5,000,003 $ (30,532,860) $ (25,532,857) Statement of Changes in Shareholders’ Equity (Deficit) for the Period from February 14, 2020 (Inception) Through December 31, 2020 Sale of 27,600,000 Units, net of underwriting discounts $ 249,366,073 $ (249,366,073) $ — Class A common stock subject to possible redemption $ (230,374,604) $ 230,374,604 $ — Accretion for Class A ordinary share subject to redemption amount $ — $ (26,721,566) $ (26,721,566) Total shareholders’ equity (deficit) $ 5,000,009 $ (45,658,843) $ (40,658,834) Statement of Changes in Shareholders’ Equity (Deficit) for the Three Months Ended March 31, 2021 Class A common stock subject to possible redemption $ (14,686,983) $ 14,686,983 $ — Accretion for Class A ordinary share subject to redemption amount $ — $ (54,865) $ (54,865) Total shareholders’ equity (deficit) $ 5,000,010 $ (31,026,725) $ (26,026,715) Statement of Changes in Shareholders’ Equity (Deficit) for the Three Months Ended June 30, 2021 Class A common stock subject to possible redemption $ (4,088,967) $ 4,088,967 $ — Accretion for Class A ordinary share subject to redemption amount $ — $ 41,715 $ 41,715 Total shareholders’ equity (deficit) $ 5,000,003 $ (35,073,977) $ (30,073,974) Statement of Cash Flows for the Period of February 14, 2020 through September 30, 2020 (unaudited) Initial classification of Class A common stock subject to possible redemption $ 244,996,570 $ 31,003,430 $ 276,000,000 Change in value of Class A common stock subject to possible redemption $ 558,209 $ (470,570) $ 87,639 Statement of Cash Flows for the Period of February 14, 2020 through December 31, 2020 (unaudited) Initial classification of Class A common stock subject to possible redemption $ 244,996,570 $ 31,003,430 $ 276,000,000 Change in value of Class A common stock subject to possible redemption $ (14,621,966) $ 14,655,413 $ 33,447 Statement of Cash Flows for the Three Months Ended March 31, 2021 Change in value of Class A common stock subject to possible redemption $ 14,686,983 $ (14,598,671) $ 88,312 Statement of Cash Flows for the Six Months Ended June 30, 2021 Change in value of Class A common stock subject to possible redemption $ 10,598,016 $ (10,551,419) $ 46,597

SUMMARY OF SIGNIFICANT ACCOUN_8

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended	11 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Sep. 30, 2021	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X promulgated under the Securities Act. Certain information or footnote disclosures normally included in condensed consolidated financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K/A, as filed with the SEC on July 8, 2021. The interim results for the three and nine months ended September 30, 2021 are not necessarily indicative of the results to be expected for the period ending December 31, 2021 or for any future periods. Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiary. All significant intercompany balances and transactions have been eliminated in consolidation. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s condensed consolidated financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these condensed consolidated financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021 and December 31, 2020. Marketable Securities Held in Trust Account At September 30, 2021 and December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. All of the Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed consolidated balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed consolidated statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. Warrant Liabilities The Company accounts for the Public Warrants (as defined in Note 3) and Private Placement Warrants (together with the Public Warrants, the “Warrants”) in accordance with the guidance contained in ASC 815-40, under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjusts the Warrants to fair value in respect of each reporting period. This liability is subject to re-measurement at each balance sheet date until the Warrants are exercised, and any change in fair value is recognized in the statements of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date. Class A Common Stock Subject to Possible Redemption The Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed consolidated balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid-in capital and accumulated deficit. At September 30, 2021 and December 31, 2020, the ordinary shares reflected in the condensed consolidated balance sheets are reconciled in the following table: Gross proceeds $ 276,000,000 Less: Proceeds allocated to Public Warrants (11,454,000) Ordinary shares issuance costs (15,179,714) Plus: Accretion of carrying value to redemption value 26,667,374 Ordinary shares subject to possible redemption, 12/31/20 276,033,447 Accretion of carrying value to redemption value (4,772) Ordinary shares subject to possible redemption, 9/30/21 $ 276,028,675 Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the condensed consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. The effective tax rates differ from the statutory tax rate for the periods presented primarily due to the change in warrant valuation and the valuation allowance recorded on the Company’s net operating losses. ASC 740 prescribes a recognition threshold and a measurement attribute for the condensed consolidated financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. Net Income (Loss) per Common Share The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common share is computed by dividing net income (loss) by the weighted average number of common shares outstanding for the period. The Company applies the two-class method in calculating income (loss) per common share. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share as the redemption value approximates fair value. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 21,320,000 shares in the calculation of diluted income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events. As of September 30, 2021 and 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common share is the same as basic net income (loss) per common share for the periods presented. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Period from Three Months Ended Nine Months Ended Three Months Ended February 14, September 30, September 30, September 30, 2020 (Inception) Through 2021 2021 2020 September 30, 2020 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per common share Numerator: Allocation of net income (loss), as adjusted $ (11,404,326) $ (2,851,082) $ (2,925,918) $ (731,480) $ (89,850) $ (23,841) $ (72,126) $ (42,565) Denominator: Basic and diluted weighted average stock outstanding 27,600,000 6,900,000 27,600,000 6,900,000 25,780,220 6,840,659 10,761,468 6,350,917 Basic and diluted net income (loss) per common share $ (0.41) $ (0.41) $ (0.11) $ (0.11) $ (0.00) $ (0.00) $ (0.01) $ (0.01) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature. The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. Recent Accounting Standards In August 2020, the FASB issued ASU No. 2020-06, “Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. The Company adopted ASU 2020-06 on January 1,2021. The adoption of ASU 2020-06 did not have an impact on the Company’s condensed consolidated financial statements. Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed consolidated financial statements.	NOTE 3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002 (“Sarbanes-Oxley Act”), reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020. Marketable Securities Held in Trust Account At December 31, 2020, substantially all of the assets held in the Trust Account were held in U.S. Treasury Bills. Warrant Liability (Restated, see Note 2 — Amendment 1) The Company accounts for the Warrants in accordance with the guidance contained in ASC 815-40-15-7D and 7F under which the Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Warrants as liabilities at their fair value and adjust the Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statement of operations. The Private Placement Warrants and the Public Warrants for periods where no observable traded price was available are valued using a Monte Carlo simulation. For periods subsequent to the detachment of the Public Warrants from the Units, the Public Warrant quoted market price was used as the fair value as of each relevant date. Class A Common Stock Subject to Possible Redemption (Restated, see Note 2 — Amendment 2) The Company accounts for its shares of Class A common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Shares of Class A common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s Class A common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s balance sheet. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid-in capital and accumulated deficit. At December 31, 2020, the common stock reflected in the balance sheets are reconciled in the following table: Gross proceeds $ 276,000,000 Less: Proceeds allocated to Public Warrants (11,454,000) Class A common stock issuance costs (15,179,927) Plus: Accretion of carrying value to redemption value 26,667,374 Class A common stock subject to possible redemption, 12/31/20 276,033,447 Income Taxes The Company follows the asset and liability method of accounting for income taxes under ASC 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. On March 27, 2020, the CARES Act was enacted in response to COVID-19 pandemic. Under ASC 740, the effects of changes in tax rates and laws are recognized in the period which the new legislation is enacted. The CARES Act made various tax law changes including among other things (i) increasing the limitation under Section 163(j) of the Internal Revenue Code of 1986, as amended (the “IRC”) for 2019 and 2020 to permit additional expensing of interest (ii) enacting a technical correction so that qualified improvement property can be immediately expensed under IRC Section 168(k), (iii) making modifications to the federal net operating loss rules including permitting federal net operating losses incurred in 2018, 2019, and 2020 to be carried back to the five preceding taxable years in order to generate a refund of previously paid income taxes and (iv) enhancing the recoverability of alternative minimum tax credits. Given the Company’s full valuation allowance position and capitalization of all costs, the CARES Act did not have an impact on the financial statements. Net (Loss) per Common Share (Restated, see Note 2 — Amendment 1) Net income (loss) per share is computed by dividing net income by the weighted-average number of shares of common stock outstanding during the period, excluding shares of common stock subject to forfeiture. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 21,320,000 shares in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events and the inclusion of such warrants would be anti-dilutive. The Company’s statement of operations includes a presentation of income (loss) per share for common shares subject to possible redemption in a manner similar to the two-class method of income (loss) per share. Net income (loss) per common share, basic and diluted, for Common stock subject to possible redemption is calculated by dividing the proportionate share of income or loss on marketable securities held by the Trust Account, net of applicable franchise and income taxes, by the weighted average number of Common stock subject to possible redemption outstanding since original issuance. Net income (loss) per share, basic and diluted, for non-redeemable common stock is calculated by dividing the net income (loss), adjusted for income or loss on marketable securities attributable to Common stock subject to possible redemption, by the weighted average number of non-redeemable common stock outstanding for the period. Non-redeemable common stock includes Founder Shares and non-redeemable shares of common stock as these shares do not have any redemption features. Non-redeemable common stock participates in the income or loss on marketable securities based on non-redeemable shares’ proportionate interest. The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts) as previously restated to reflect Amendment 1 only. See Amendment 2 following this amendment to reflect the amounts, as restated, per the financial statements: For the Period from February 14, 2020 (Inception) Through December 31, 2020 Class A Common Stock Subject to Possible Redemption Numerator: Earnings allocable to Class A common stock subject to possible redemption Interest earned on marketable securities held in Trust Account $ 174,810 Less: interest available to be withdrawn for payment of taxes (146,895) Less: interest available to be withdrawn for working capital — Net income attributable to Class A common stock subject to possible redemption $ 27,915 Denominator: Weighted Average Class A common stock subject to possible redemption Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 24,524,620 Basic and diluted net income per share, Class A common stock subject to possible redemption $ 0.00 Non-Redeemable Common Stock Numerator: Net Loss minus Net Earnings Net loss $ (15,294,860) Net income allocable to Class A common stock subject to possible redemption (27,915) Non-Redeemable Net Loss $ (15,322,775) Denominator: Weighted Average Non-redeemable common Stock Basic and diluted weighted average shares outstanding, Non-redeemable common stock 8,269,814 Basic and diluted net loss per share, Non-redeemable common stock $ (1.85) As discussed in Note 2, the financial statements as of December 31, 2020 and for the period from February 14, 2020 (inception) through December 31, 2020 have been restated (Amendment 1 - presentation of warrant liability and Amendment 2 - presentation of class A common stock subject to possible redemption). The information provided under this section was prepared in connection with Amendment 1-presentation of warrant liability, and has been amended and restated in connection with Amendment 2 - presentation of class A common stock subject to possible redemption, as described below under “Net Loss per Common Share (Restated, see Note 1 - Amendment 2)”. Net Loss per Common Share (Restated, see Note 2 — Amendment 2) The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “ Earnings Per Share”. Net loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding for the period. The Company applies the two-class method in calculating income (loss) per common share. Accretion associated with the redeemable shares of Class A common stock is excluded from income (loss) per common share as the redemption value approximates fair value. The Company has not considered the effect of the warrants sold in the Initial Public Offering and private placement to purchase an aggregate of 21,320,000 shares in the calculation of diluted income (loss) per share, since the exercise of the warrants is contingent upon the occurrence of future events. As of December 31, 2020 and September 31, 2020, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net loss per common share is the same as basic net loss per common share for the periods presented. The following table reflects the calculation of basic and diluted net loss per common share (in dollars, except per share amounts), as restated: For the Period from February 14, 2020 (inception) Through December 31, 2020 Class A Class B Basic and diluted net loss per common share Numerator: Allocation of net loss, as adjusted (10,821,703) (4,473,157) Denominator: — Basic and diluted weighted average stock outstanding 15,758,710 6,513,871 Basic and diluted net loss per common share (0.69) (0.69) Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Fair value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Fair Value Measurements (Restated, see Note 2 — Amendment 1) The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: Level 1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. Level 2: Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. Level 3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. Recent Accounting Standards Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

PUBLIC OFFERING_2

PUBLIC OFFERING	9 Months Ended	11 Months Ended
PUBLIC OFFERING	Sep. 30, 2021	Dec. 31, 2020
PUBLIC OFFERING
PUBLIC OFFERING	NOTE 4. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 27,600,000 Units, which includes the full exercise by the underwriters of their option to purchase an additional 3,600,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one -half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 9).	NOTE 4. PUBLIC OFFERING Pursuant to the Initial Public Offering, the Company sold 27,600,000 Units, which includes the full exercise by the underwriters of their option to purchase an additional 3,600,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock and one -half of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment (see Note 8).

PRIVATE PLACEMENT_2

PRIVATE PLACEMENT	9 Months Ended	11 Months Ended
PRIVATE PLACEMENT	Sep. 30, 2021	Dec. 31, 2020
PRIVATE PLACEMENT.
PRIVATE PLACEMENT	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, on July 7, 2020, the Sponsor purchased an aggregate of 7,520,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $7,520,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. The proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants.	NOTE 5. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, on July 7, 2020, the Sponsor purchased an aggregate of 7,520,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, for an aggregate purchase price of $7,520,000. Each Private Placement Warrant is exercisable to purchase one share of Class A common stock at a price of $11.50 per share. The proceeds from the Private Placement Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds of the sale of the Private Placement Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless. There will be no redemption rights or liquidating distributions from the Trust Account with respect to the Private Placement Warrants.

RELATED PARTY TRANSACTIONS_2

RELATED PARTY TRANSACTIONS	9 Months Ended	11 Months Ended
RELATED PARTY TRANSACTIONS	Sep. 30, 2021	Dec. 31, 2020
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On February 26, 2020, the Sponsor purchased 5,750,000 shares of the Company’s Class B common stock (the “Founder Shares”) for an aggregate price of $25,000. On July 1, 2020, the Company effected a stock dividend of 1,150,000 shares, resulting in the Company’s initial stockholders holding an aggregate of 6,900,000 Founder Shares. The Founder Shares included an aggregate of up to 900,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. All share and per-share amounts have been retroactively restated to reflect the stock dividend. As a result of the underwriters’ election to fully exercise their over-allotment option, no Founder Shares are currently subject to forfeiture. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Administrative Support Agreement The Company entered into an agreement, commencing on July 1, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. For the three and nine months ended September 30, 2021, the Company incurred $30,000 and $90,000 in fees for these services, respectively. At September 30, 2021, $10,000 of such fees was included in account payable and accrued expense in the condensed consolidated balance sheet. Promissory Note — Related Party On February 14, 2020, the Sponsor agreed to loan the Company an aggregate of up to $250,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”). The Promissory Note was non-interest bearing and payable on the earlier of July 31, 2020 or the completion of the Initial Public Offering. The outstanding balance under the Promissory Note of $140,000 was repaid at the closing of the Initial Public Offering on July 7, 2020. Borrowings under the Promissory Note are no longer available. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. On March 3, 2021, the Sponsor committed to provide the Company an aggregate of $1,500,000 in loans for working capital purposes on an as needed basis. Such loans will be evidenced by a promissory note when issued. As of September 30, 2021 and December 31, 2020, there were no amounts outstanding under the Working Capital Loans. Sponsor Loan On July 28, 2021, the Sponsor committed to provide the Company an aggregate of $4,000,000 in loans for working capital purposes. These loans will be non-interest bearing, unsecured and will be repaid upon the consummation of a Business Combination. If the Company does not consummate a Business Combination, all amounts loaned to the Company in connection with these loans will be forgiven except to the extent that the Company has funds available to it outside of its Trust Account. As of September 30, 2021, there were no amounts outstanding under these loans.	NOTE 6. RELATED PARTY TRANSACTIONS Founder Shares On February 26, 2020, the Sponsor purchased 5,750,000 shares of the Company’s Class B common stock (the “Founder Shares”) for an aggregate price of $25,000. On July 1, 2020, the Company effected a stock dividend of 1,150,000 shares, resulting in the Company’s initial stockholders holding an aggregate of 6,900,000 Founder Shares. The Founder Shares included an aggregate of up to 900,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so that the Sponsor would own, on an as-converted basis, 20% of the Company’s issued and outstanding shares after the Initial Public Offering. All share and per-share amounts have been retroactively restated to reflect the stock dividend. As a result of the underwriters’ election to fully exercise their over-allotment option, no Founder Shares are currently subject to forfeiture. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) one year after the completion of a Business Combination or (B) subsequent to a Business Combination, (x) if the last sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading Administrative Support Agreement The Company entered into an agreement, commencing on July 1, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor a total of $10,000 per month for office space, utilities and secretarial and administrative support. For the period from February 14, 2020 (inception) through December 31, 2020, the Company incurred and paid $60,000 in fees for these services, of which such amount is included in accrued expenses in the accompanying balance sheet. Promissory Note — Related Party On February 14, 2020, the Sponsor agreed to loan the Company an aggregate of up to $250,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”). The Promissory Note was non-interest bearing and payable on the earlier of July 31, 2020 or the completion of the Initial Public Offering. The outstanding balance under the Promissory Note of $150,000 was repaid at the closing of the Initial Public Offering on July 7, 2020. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor, an affiliate of the Sponsor, or the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants.

COMMITMENTS_2

COMMITMENTS	9 Months Ended	11 Months Ended
COMMITMENTS	Sep. 30, 2021	Dec. 31, 2020
COMMITMENTS
COMMITMENTS	NOTE 7. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on July 1, 2020, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of the majority of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination, subject to the terms of the underwriting agreement. Business Combination Agreement On July 19, 2021, the Company entered into a Business Combination Agreement (as it may be amended, supplemented or otherwise modified from time to time, the “ Business Combination Agreement The Business Combination Agreement and the transactions contemplated thereby were approved by the board of directors of each of the Company and Gelesis. The Business Combination Agreement provides for, among other things, that Merger Sub will merge with and into Gelesis, with Gelesis as the surviving company in the merger and, after giving effect to such merger, Gelesis shall be a wholly-owned subsidiary of the Company (the “Merger ” In accordance with the terms and subject to the conditions of the Business Combination Agreement, at the Effective Time, (i) each share of Gelesis outstanding as of immediately prior to the Effective Time will be exchanged for shares of the Company’s common stock, par value $0.0001 per share (“CPSR Shares”) based on an implied Gelesis equity value of $900,000,000; (ii) all vested and unvested stock options of Gelesis will be assumed by the Company and thereafter be settled or exercisable for CPSR Shares, as applicable, determined based on the same implied Gelesis equity value described in clause (i); (iii) each warrant of Gelesis will be canceled in exchange for a warrant to purchase shares of the Company determined based on the same implied Gelesis equity value described in clause (i); and (iv) each share of the Company’s Class A common stock, par value $0.0001 per share (the “ CPSR Class A Common Stock CPSR Class B Common Stock 20 30 On November 8, 2021, CPSR, Merger Sub and Gelesis entered into an Amendment to the Original Business Combination Agreement (the “Business Combination Agreement Amendment,” and together with the Original Business Combination Agreement, the “Business Combination Agreement”), which, among other things (i) adjusts the equity valuation of Gelesis from $900,000,000 to $675,000,000, (ii) increases the number of Earn Out Shares (as defined in the Business Combination Agreement) available to be issued to Company Stockholders (as defined in the Business Combination Agreement) from 15,000,000 to 23,483,250, (iii) provides for the issuance of 1,983,750 additional Capstar Class A Shares to Company Stockholders, equal to the number of Capstar Class B Shares forfeited by the Sponsor and certain affiliates of the Sponsor in accordance with the Sponsor Letter Agreement Amendment (as defined and described in further detail below), and (iv) extends the Termination Date (as defined in the Business Combination Agreement) from January 18, 2022 to January 31, 2022. In connection, and concurrently, with the execution of the Business Combination Agreement Amendment, Capstar, Capstar Sponsor Group LLC, a Delaware limited liability company (the “Sponsor”), certain affiliates of the Sponsor and Gelesis entered into an amendment (the “Sponsor Letter Agreement Amendment”) to that certain Sponsor Letter Agreement, dated July 19, 2021. Pursuant to the Sponsor Letter Agreement Amendment, the parties thereto further agreed, among other things, that (i) the vesting provisions relating to Capstar Class B Shares (as defined in the Sponsor Letter Agreement) be deleted and (ii) as of immediately prior to the Effective Time (as defined in the Sponsor Letter Agreement), 1,983,750 Capstar Class B Shares held by the Sponsor and certain affiliates of the Sponsor be surrendered to Capstar for cancellation upon such surrender, without any consideration for such surrender. The Business Combination is expected to close in the fourth quarter of 2021, following the receipt of the required approval by the Company’s stockholders and the fulfillment of other customary closing conditions.	NOTE 7. COMMITMENTS Registration Rights Pursuant to a registration rights agreement entered into on July 1, 2020, the holders of the Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans (and any shares of Class A common stock issuable upon the exercise of the Private Placement Warrants or warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion to Class A common stock). The holders of the majority of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters are entitled to a deferred fee of $0.35 per Unit, or $9,660,000 in the aggregate. The deferred fee will be waived by the underwriters in the event that the Company does not complete a Business Combination, subject to the terms of the underwriting agreement.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	9 Months Ended	11 Months Ended
STOCKHOLDERS' EQUITY	Sep. 30, 2021	Dec. 31, 2020
STOCKHOLDERS' DEFICIT
STOCKHOLDERS' DEFICIT	NOTE 8. STOCKHOLDERS’ DEFICIT Preferred Stock Class A Common Stock Class B Common Stock outstanding Holders of Class B common stock will have the right to elect all of the Company’s directors prior to a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company).	NOTE 8. STOCKHOLDERS’ DEFICIT ( Restated, see Note 2 — Amendment 2 Preferred Stock — outstanding Class A Common Stock — issued outstanding Class B Common Stock — outstanding Holders of Class B common stock will have the right to elect all of the Company’s directors prior to a Business Combination. Holders of Class A common stock and Class B common stock will vote together as a single class on all other matters submitted to a vote of stockholders except as required by law. The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of a Business Combination on a one-for-one basis, subject to adjustment. In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts offered in the Initial Public Offering and related to the closing of a Business Combination, the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with a Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in a Business Combination, and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of loans made to the Company).

WARRANTS_2

WARRANTS	9 Months Ended
WARRANTS	Sep. 30, 2021
WARRANTS.
WARRANTS	NOTE 9. WARRANTS As of September 30, 2021 and December 31, 2020, there were 13,800,000 Public Warrants outstanding. Public Warrants may only be exercised for a whole number of shares. No fractional warrants will be issued upon separation of the Units and only whole warrants will trade. The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act covering the issuance of the shares of Class A common issuable upon exercise of the warrants is then effective and a current prospectus relating to those shares of Class A common stock is available, subject to the Company satisfying its obligations with respect to registration. No warrant will be exercisable and we will not be obligated to issue shares of Class A common stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. The Company has agreed that as soon as practicable, but in no event later than 15 business days after the closing of a Business Combination, the Company will use its best efforts to file with the SEC a registration statement covering the issuance of the shares of Class A common stock issuable upon exercise of the warrants to cause such registration statement to become effective and to maintain a current prospectus relating to those shares of Class A common stock until the warrants expire or are redeemed, as specified in the warrant agreement. If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60 th business day after the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. Once the warrants become exercisable, the Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon not less than 30 days’ prior written notice of redemption to each warrant holder; and ● if, and only if, the reported last sale price of the Company’s Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 - trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company, the Company may not exercise its redemption right if the issuance of shares of common stock upon exercise of the warrants is not exempt from registration or qualification under applicable state blue sky laws or the Company is unable to effect such registration or qualification. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of Class A common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of Class A common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates a Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. As of September 30, 2021 and December 31, 2020, there were 7,520,000 Private Placement Warrants outstanding. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants and the Class A common stock issuable upon the exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended	11 Months Ended
FAIR VALUE MEASUREMENTS	Sep. 30, 2021	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
FAIR VALUE MEASUREMENTS	NOTE 10. FAIR VALUE MEASUREMENTS The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, 2021 December 31, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 276,178,675 $ 276,209,453 Liabilities: Warrant Liability – Public Warrants 1 $ 12,006,000 $ 19,458,000 Warrant Liability – Private Placement Warrants 3 $ 20,380,148 $ 10,643,808 The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities in the accompanying condensed consolidated balance sheets. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the condensed consolidated statements of operations. Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. The fair value of the Private Placement Warrants was estimated at September 30, 2021 and December 31, 2020 to be $2.71 per warrant and $1.42 per warrant, respectively, using the modified Black-Scholes option pricing model and the following assumptions: September 30, December 31, 2021 2020 Risk-free interest rate 1.02 % 0.47 % Expected Term 5.25 5.76 Dividend yield 0.00 % 0.00 % Expected volatility 13.5 % 19.0 % Exercise price $ 11.50 $ 11.50 Unit Price $ 9.92 $ 10.15 The following table presents the changes in the fair value of Level 3 warrant liabilities: Private Placement Fair value as of December 31, 2020 $ 10,643,808 Change in fair value (5,273,024) Fair value as of March 31, 2021 5,370,784 Change in fair value 1,422,600 Fair value as of June 30, 2021 6,793,384 Change in fair value 13,586,764 Fair value as of September 30, 2021 20,380,148 There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three and nine months ended September 30, 2021.	NOTE 11. FAIR VALUE MEASUREMENTS (Restated, See Note 2 — Amendment 1) The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 276,209,453 Liabilities: Warrant Liability — Public Warrants 1 19,458,000 Warrant Liability — Private Placement Warrants 3 10,643,808 The Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the balance sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the consolidated statement of operations. Initial Measurement The Company established the initial fair value for the Warrants on July 7, 2020, the date of the Company’s Initial Public Offering, using a Monte Carlo Simulation for the Private Placement Warrants and the Public Warrants. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of Class A common stock and one-half of one Public Warrant), (ii) the sale of Private Placement Warrants, and (iii) the issuance of shares of Class B common stock, first to the Warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to shares of Class A common stock subject to possible redemption, shares of Class A common stock and shares of Class B common stock based on their relative fair values at the initial measurement date. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. The key inputs into the Monte Carlo simulation model for the Private Placement Warrants and Public Warrants were as follows at initial measurement: July 7, 2020 (Initial Input Measurement) Risk-free interest rate 0.39 % Tine to maturity 6.0 Dividend yield 0.00 % Expected volatility 10.0 % Exercise price $ 11.50 Unit Price $ 10.18 On July 7, 2020, the Private Placement Warrants and Public Warrants were determined to be $0.83 per warrant for aggregate values of $6.24 million and 11.45 million, respectively. Subsequent Measurement The Warrants are measured at fair value on a recurring basis. The subsequent measurement of the Public Warrants as of December 31, 2020 is classified as Level 1 due to the use of an observable market quote in an active market. The subsequent measurement of the Private Placement Warrants was calculated using a Black Scholes Merton model which is considered a Level 3 measurement. The key inputs into the Black Scholes Merton model for the Private Placement Warrants were as follows at December 31, 2020: Input Risk-free interest rate 0.47 % Expected Term 5.76 Dividend yield 0.00 % Expected volatility 19.0 % Exercise price $ 11.50 Unit Price $ 10.15 As of December 31, 2020, the aggregate values of the Private Placement Warrants and Public Warrants were $19.46 million and $10.64 million, respectively. The following table presents the changes in the fair value of warrant liabilities: Private Placement Public Warrant Liabilities Fair value as of January 1, 2020 $ — $ — $ — Initial measurement on July 7, 2020 (IPO) 6,241,600 11,454,000 17,695,600 Change in valuation inputs or other assumptions 4,402,208 8,004,000 12,406,208 Fair value as of December 31, 2020 $ 10,643,808 $ 19,458,000 $ 30,101,808 Due to the use of quoted prices in an active market (Level 1) to measure the fair value of the Public Warrants, subsequent to initial measurement, the Company had transfers out of Level 3 totaling approximately $11.1 million during the period from July 7, 2020 through December 31, 2020. Level 3 financial liabilities consist of the Private Placement Warrant liability for which there is no current market for these securities such that the determination of fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. See Note 2 for a discussion on the restatement of the Company’s financial statements.

SUBSEQUENT EVENTS_2

SUBSEQUENT EVENTS	9 Months Ended	11 Months Ended
SUBSEQUENT EVENTS	Sep. 30, 2021	Dec. 31, 2020
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 11. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed consolidated financial statements were issued. Based upon this review, other than the below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements. As described in Note 7, the Company entered into a Business Combination Agreement on July 19, 2021 and entered into a Business Combination Agreement Amendment on November 8, 2021. In connection, and concurrently, with the execution of the Business Combination Agreement Amendment, Capstar, Capstar Sponsor Group LLC (the “Sponsor”), certain affiliates of the Sponsor and Gelesis entered into an amendment to that certain Sponsor Letter Agreement, dated July 19, 2021.	NOTE 12. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On March 3, 2021, the Sponsor committed to provide the Company an aggregate of $1,500,000 in loans for working capital purposes on an as needed basis. Such loans will be evidenced by a promissory note when issued. On July 19, 2021, we entered into a Business Combination Agreement with CPSR Gelesis Merger Sub, Inc. (“Merger Sub”) and Gelesis, Inc. (“Gelesis”) which was amended on November 8, 2021. The Business Combination Agreement and the transactions contemplated thereby were approved by the board of directors of each of CPSR and Gelesis. The Business Combination Agreement provides for, among other things, that Merger Sub will merge with and into Gelesis, with Gelesis as the surviving company in the merger and, after giving effect to such merger, Gelesis shall be our wholly-owned subsidiary (the time that the business combination becomes effective being referred to as the “Effective Time”). In addition, we will be renamed Gelesis Holdings, Inc. In accordance with the terms and subject to the conditions of the Business Combination Agreement, at the Effective Time, (i) each share of Gelesis outstanding as of immediately prior to the Effective Time will be exchanged for shares in the post-combination company (“CPSR Shares”) based on an implied Gelesis equity value of $675,000,000, (ii) all vested and unvested stock options of Gelesis will be assumed by us and thereafter be settled or exercisable for CPSR Shares, as applicable, determined based on the same implied Gelesis equity value described in clause (i); (iii) each warrant of Gelesis will be canceled in exchange for a warrant to purchase our shares of determined based on the same implied Gelesis equity value described in clause (i); and (iv) each share of CPSR Class A common stock and each share of CPSR Class B common stock that is issued and outstanding immediately prior to the Effective Time shall become one CPSR Share following the consummation of the Business Combination. In addition, each holder of shares of Gelesis common stock, options and warrants will receive its pro rata portion of 23,483,250 restricted earn out CPSR Shares, which will vest (in part) in equal thirds if the trading price of CPSR Shares is greater than or equal to $12.50, $15.00 and $17.50, respectively, for any 20 trading days within any 30 -trading day period on or prior to the date that is five years following the Effective Time (the “Earn Out Period”) and will also vest in connection with any change of control transaction with respect to us if the applicable thresholds are met in such change of control transaction during the Earn Out Period. The amendment to the Business Combination Agreement extended the Termination Date (as defined in the Business Combination Agreement) from January 18, 2022 to January 31, 2022. Concurrently with the execution of the Business Combination Agreement, the Company entered into subscription agreements (the “Subscription Agreements”) with each of the PIPE Investors (as defined in the Business Combination Agreement), pursuant to which the PIPE Investors agreed to subscribe for and purchase, and the Company agreed to issue and sell to the PIPE Investors, an aggregate of 9,000,000 shares of Class A Common Stock at a price of $10.00 per share, for aggregate gross proceeds of $90 million, subject to the terms and conditions of the Subscription Agreements and the other agreements with the PIPE Investors (the “PIPE Financing”). Concurrently with the execution of the Business Combination Agreement, the Sponsor, certain affiliates of the Sponsor and Gelesis entered into the Sponsor Letter Agreement, as amended on November 8, 2021 (the “Sponsor Letter Agreement”), pursuant to which (x) such affiliates of the Sponsor have agreed to, among other things, (i) vote in favor of the Business Combination Agreement and the transactions contemplated thereby, (ii) waive any adjustment to the conversion ratio set forth in the governing documents of the Company or any other anti-dilution or similar protection with respect to the shares of Class B Common Stock (whether resulting from the transactions contemplated by the Subscription Agreements or otherwise), such that the shares of Class B Common Stock will convert into shares of the post-combination company at the closing of the business combination transaction on a one-to-one basis, (iii) be bound by certain other covenants and agreements related to the business combination and (iv) be bound by certain transfer restrictions with respect to his, her or its shares in the Company prior to the closing of the business combination, (y) the Sponsor will subject certain of the warrants to purchase Class A Common Stock currently held by it to certain vesting conditions and potential forfeiture as follows: the warrants subject to the vesting conditions and potential forfeiture (the number of which warrants will be prorated to reflect the proportionate amount of Company stockholder redemptions) will vest (and no longer be subject to forfeiture) at such time during the period from and after the closing of the business combination through and until the date that is five (5) years after the closing date (the “Sponsor Vesting Period”) (i) if the trading price of shares of the post-combination company is greater than or equal to $20.00 for any 20 trading days within any period of 30 consecutive trading days or (ii) there is a Capstar Sale (as defined in the Business Combination Agreement) in which the sale price for the acquisition of the post-combination company shares is greater than or equal to $20.00, in each case, during the Sponsor Vesting Period and (z) as of immediately prior to the Effective Time, the Sponsor will forfeit certain of its founders shares to the Company for cancellation without any consideration, in each case, on the terms and subject to the conditions set forth in the Sponsor Letter Agreement.

SUMMARY OF SIGNIFICANT ACCOUN_9

RESTATEMENT OF PREVIOUSLY ISS_5

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Tables)	9 Months Ended
	Sep. 30, 2021
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
Summary of impact of the restatement on the financial statements	As Previously Reported Adjustment As Restated Balance Sheet as of July 7, 2020 Class A common stock subject to possible redemption $ 244,996,570 $ 31,003,430 $ 276,000,000 Class A common stock $ 310 $ (310) $ — Additional paid-in capital $ 5,671,903 $ (5,671,903) $ — Accumulated deficit $ (672,901) $ (25,331,217) $ (26,004,118) Total stockholders’ equity (deficit) $ 5,000,002 $ (31,003,430) $ (26,003,428) Number of shares subject to redemption 24,499,657 3,100,343 27,600,000 Balance Sheet as of September 30, 2020 Class A common stock subject to possible redemption $ 245,554,779 $ 30,532,860 $ 276,087,639 Class A common stock $ 305 $ (305) $ — Additional paid-in capital $ 5,113,699 $ (5,113,699) $ — Accumulated deficit $ (114,691) $ (25,418,856) $ (25,533,547) Total stockholders’ equity (deficit) $ 5,000,003 $ (30,532,860) $ (25,532,857) Number of shares subject to redemption 24,547,683 3,052,317 27,600,000 Balance Sheet as of December 31, 2020 Class A common stock subject to possible redemption $ 230,374,604 $ 45,658,843 $ 276,033,447 Class A common stock $ 457 $ (457) $ — Additional paid-in capital $ 20,293,722 $ (20,293,722) $ — Accumulated deficit $ (15,294,860) $ (25,364,664) $ (40,659,524) Total stockholders’ equity (deficit) $ 5,000,009 $ (45,658,843) $ (40,658,834) Number of shares subject to redemption 23,034,669 4,565,331 27,600,000 Balance Sheet as of March 31, 2021 Class A common stock subject to possible redemption $ 245,061,587 $ 31,026,725 $ 276,088,312 Class A common stock $ 311 $ (311) $ — Additional paid-in capital $ 5,606,885 $ (5,606,885) $ — Accumulated deficit $ (607,876) $ (25,419,529) $ (26,027,405) Total stockholders’ equity (deficit) $ 5,000,010 $ (31,026,725) $ (26,026,715) Number of shares subject to redemption 24,493,884 3,106,116 27,600,000 Balance Sheet as of June 30, 2021 Class A common stock subject to possible redemption $ 240,972,620 $ 35,073,977 $ 276,046,597 Class A common stock $ 352 $ (352) $ — Additional paid-in capital $ 9,695,811 $ (9,695,811) $ — Accumulated deficit $ (4,696,850) $ (25,377,814) $ (30,074,664) Total stockholders’ equity (deficit) $ 5,000,003 $ (35,073,977) $ (30,073,974) Number of shares subject to redemption 24,084,470 3,515,530 27,600,000 Statement of Operations for the Period from February 14, 2020 (Inception) Through September 30, 2020 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 24,499,657 (24,499,657) — Basic and diluted weighted average shares outstanding, Non-redeemable common stock 7,559,767 (7,559,767) — Basic and diluted net loss per share, Non-redeemable common stock $ (0.02) $ 0.02 $ — Weighted average shares outstanding of Class A common stock — 10,761,468 10,761,468 Basic and diluted net loss per share, Class A common stock $ — $ (0.01) $ (0.01) Weighted average shares outstanding of Class B common stock — 6,350,917 6,350,917 Basic and diluted net loss per share, Class B common stock $ — $ (0.01) $ (0.01) Statement of Operations for the Period from February 14, 2020 (Inception) Through December 31, 2020 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 24,524,620 (24,524,620) — Basic and diluted weighted average shares outstanding, Non-redeemable common stock 8,269,814 (8,269,814) — Basic and diluted net loss per share, Non-redeemable common stock $ (1.85) $ 1.85 $ — Weighted average shares outstanding of Class A common stock — 15,758,710 15,758,710 Basic and diluted net loss per share, Class A common stock $ — $ (0.69) $ (0.69) Weighted average shares outstanding of Class B common stock — 6,513,871 6,513,871 Basic and diluted net loss per share, Class B common stock $ — $ (0.69) $ (0.69) Statement of Operations for the Three Months Ended March 31, 2021 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 23,034,669 (23,034,669) — Basic and diluted weighted average shares outstanding, Non-redeemable common stock 11,465,331 (11,465,331) — Basic and diluted net income per share, Non-redeemable common stock $ 1.28 $ (1.28) $ — Weighted average shares outstanding of Class A common stock — 27,600,000 27,600,000 Basic and diluted net income per share, Class A common stock $ — $ 0.43 $ 0.43 Weighted average shares outstanding of Class B common stock — 6,900,000 6,900,000 Basic and diluted net income per share, Class B common stock $ — $ 0.43 $ 0.43 As Previously Reported Adjustment As Restated Statement of Operations for the Three Months Ended June 30, 2021 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 24,493,884 (24,493,884) — Basic and diluted weighted average shares outstanding, Non-redeemable common stock 10,006,116 (10,006,116) — Basic and diluted net loss per share, Non-redeemable common stock $ (0.41) $ 0.41 $ — Weighted average shares outstanding of Class A common stock — 27,600,000 27,600,000 Basic and diluted net loss per share, Class A common stock $ — $ — $ — Weighted average shares outstanding of Class B common stock — 6,900,000 6,900,000 Basic and diluted net loss per share, Class B common stock $ — $ (0.59) $ (0.59) Statement of Operations for the Six Months Ended June 30, 2021 Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 23,768,307 (23,768,307) — Basic and diluted weighted average shares outstanding, Non-redeemable common stock 10,731,693 (10,731,693) — Basic and diluted net income per share, Non-redeemable common stock $ 0.99 $ (0.99) $ — Weighted average shares outstanding of Class A common stock — 27,600,000 27,600,000 Basic and diluted net income per share, Class A common stock $ — $ 0.31 $ 0.31 Weighted average shares outstanding of Class B common stock — 6,900,000 6,900,000 Basic and diluted net income per share, Class B common stock $ — $ 0.31 $ 0.31 Statement of Changes in Shareholders’ Equity (Deficit) for the Period from February 14, 2020 (Inception) Through September 30, 2020 Sale of 27,600,000 Units, net of underwriting discounts $ 249,366,073 $ (249,366,073) $ — Class A common stock subject to possible redemption $ (245,554,775) $ 245,554,775 $ — Accretion for Class A ordinary share subject to redemption amount $ — $ (26,721,566) $ (26,721,566) Total shareholders’ equity (deficit) $ 5,000,003 $ (30,532,860) $ (25,532,857) Statement of Changes in Shareholders’ Equity (Deficit) for the Period from February 14, 2020 (Inception) Through December 31, 2020 Sale of 27,600,000 Units, net of underwriting discounts $ 249,366,073 $ (249,366,073) $ — Class A common stock subject to possible redemption $ (230,374,604) $ 230,374,604 $ — Accretion for Class A ordinary share subject to redemption amount $ — $ (26,721,566) $ (26,721,566) Total shareholders’ equity (deficit) $ 5,000,009 $ (45,658,843) $ (40,658,834) Statement of Changes in Shareholders’ Equity (Deficit) for the Three Months Ended March 31, 2021 Class A common stock subject to possible redemption $ (14,686,983) $ 14,686,983 $ — Accretion for Class A ordinary share subject to redemption amount $ — $ (54,865) $ (54,865) Total shareholders’ equity (deficit) $ 5,000,010 $ (31,026,725) $ (26,026,715) Statement of Changes in Shareholders’ Equity (Deficit) for the Three Months Ended June 30, 2021 Class A common stock subject to possible redemption $ (4,088,967) $ 4,088,967 $ — Accretion for Class A ordinary share subject to redemption amount $ — $ 41,715 $ 41,715 Total shareholders’ equity (deficit) $ 5,000,003 $ (35,073,977) $ (30,073,974) Statement of Cash Flows for the Period of February 14, 2020 through September 30, 2020 (unaudited) Initial classification of Class A common stock subject to possible redemption $ 244,996,570 $ 31,003,430 $ 276,000,000 Change in value of Class A common stock subject to possible redemption $ 558,209 $ (470,570) $ 87,639 Statement of Cash Flows for the Period of February 14, 2020 through December 31, 2020 (unaudited) Initial classification of Class A common stock subject to possible redemption $ 244,996,570 $ 31,003,430 $ 276,000,000 Change in value of Class A common stock subject to possible redemption $ (14,621,966) $ 14,655,413 $ 33,447 Statement of Cash Flows for the Three Months Ended March 31, 2021 Change in value of Class A common stock subject to possible redemption $ 14,686,983 $ (14,598,671) $ 88,312 Statement of Cash Flows for the Six Months Ended June 30, 2021 Change in value of Class A common stock subject to possible redemption $ 10,598,016 $ (10,551,419) $ 46,597

SUMMARY OF SIGNIFICANT ACCOU_10

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended	11 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	Sep. 30, 2021	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of ordinary shares	At September 30, 2021 and December 31, 2020, the ordinary shares reflected in the condensed consolidated balance sheets are reconciled in the following table: Gross proceeds $ 276,000,000 Less: Proceeds allocated to Public Warrants (11,454,000) Ordinary shares issuance costs (15,179,714) Plus: Accretion of carrying value to redemption value 26,667,374 Ordinary shares subject to possible redemption, 12/31/20 276,033,447 Accretion of carrying value to redemption value (4,772) Ordinary shares subject to possible redemption, 9/30/21 $ 276,028,675
Schedule of Earnings Per Share, Basic and Diluted	The following table reflects the calculation of basic and diluted net income (loss) per common share (in dollars, except per share amounts): For the Period from Three Months Ended Nine Months Ended Three Months Ended February 14, September 30, September 30, September 30, 2020 (Inception) Through 2021 2021 2020 September 30, 2020 Class A Class B Class A Class B Class A Class B Class A Class B Basic and diluted net income (loss) per common share Numerator: Allocation of net income (loss), as adjusted $ (11,404,326) $ (2,851,082) $ (2,925,918) $ (731,480) $ (89,850) $ (23,841) $ (72,126) $ (42,565) Denominator: Basic and diluted weighted average stock outstanding 27,600,000 6,900,000 27,600,000 6,900,000 25,780,220 6,840,659 10,761,468 6,350,917 Basic and diluted net income (loss) per common share $ (0.41) $ (0.41) $ (0.11) $ (0.11) $ (0.00) $ (0.00) $ (0.01) $ (0.01)	For the Period from February 14, 2020 (Inception) Through December 31, 2020 Class A Common Stock Subject to Possible Redemption Numerator: Earnings allocable to Class A common stock subject to possible redemption Interest earned on marketable securities held in Trust Account $ 174,810 Less: interest available to be withdrawn for payment of taxes (146,895) Less: interest available to be withdrawn for working capital — Net income attributable to Class A common stock subject to possible redemption $ 27,915 Denominator: Weighted Average Class A common stock subject to possible redemption Basic and diluted weighted average shares outstanding, Class A common stock subject to possible redemption 24,524,620 Basic and diluted net income per share, Class A common stock subject to possible redemption $ 0.00 Non-Redeemable Common Stock Numerator: Net Loss minus Net Earnings Net loss $ (15,294,860) Net income allocable to Class A common stock subject to possible redemption (27,915) Non-Redeemable Net Loss $ (15,322,775) Denominator: Weighted Average Non-redeemable common Stock Basic and diluted weighted average shares outstanding, Non-redeemable common stock 8,269,814 Basic and diluted net loss per share, Non-redeemable common stock $ (1.85) For the Period from February 14, 2020 (inception) Through December 31, 2020 Class A Class B Basic and diluted net loss per common share Numerator: Allocation of net loss, as adjusted (10,821,703) (4,473,157) Denominator: — Basic and diluted weighted average stock outstanding 15,758,710 6,513,871 Basic and diluted net loss per common share (0.69) (0.69)

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended	11 Months Ended
FAIR VALUE MEASUREMENTS (Tables)	Sep. 30, 2021	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
Schedule of Company's assets that are measured at fair value on a recurring basis	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at September 30, 2021 and December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level September 30, 2021 December 31, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 276,178,675 $ 276,209,453 Liabilities: Warrant Liability – Public Warrants 1 $ 12,006,000 $ 19,458,000 Warrant Liability – Private Placement Warrants 3 $ 20,380,148 $ 10,643,808	The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at December 31, 2020, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description Level December 31, 2020 Assets: Cash and marketable securities held in Trust Account 1 $ 276,209,453 Liabilities: Warrant Liability — Public Warrants 1 19,458,000 Warrant Liability — Private Placement Warrants 3 10,643,808
Schedule of fair value measurement inputs and valuation techniques	The fair value of the Private Placement Warrants was estimated at September 30, 2021 and December 31, 2020 to be $2.71 per warrant and $1.42 per warrant, respectively, using the modified Black-Scholes option pricing model and the following assumptions: September 30, December 31, 2021 2020 Risk-free interest rate 1.02 % 0.47 % Expected Term 5.25 5.76 Dividend yield 0.00 % 0.00 % Expected volatility 13.5 % 19.0 % Exercise price $ 11.50 $ 11.50 Unit Price $ 9.92 $ 10.15
Schedule of change in the fair value of the warrant liabilities	The following table presents the changes in the fair value of Level 3 warrant liabilities: Private Placement Fair value as of December 31, 2020 $ 10,643,808 Change in fair value (5,273,024) Fair value as of March 31, 2021 5,370,784 Change in fair value 1,422,600 Fair value as of June 30, 2021 6,793,384 Change in fair value 13,586,764 Fair value as of September 30, 2021 20,380,148	Private Placement Public Warrant Liabilities Fair value as of January 1, 2020 $ — $ — $ — Initial measurement on July 7, 2020 (IPO) 6,241,600 11,454,000 17,695,600 Change in valuation inputs or other assumptions 4,402,208 8,004,000 12,406,208 Fair value as of December 31, 2020 $ 10,643,808 $ 19,458,000 $ 30,101,808

DESCRIPTION OF ORGANIZATION A_4

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details)	Jul. 07, 2020USD ($)$ / sharesshares	Feb. 14, 2020item	Sep. 30, 2021USD ($)	Sep. 30, 2020USD ($)	Sep. 30, 2020USD ($)shares	Sep. 30, 2021USD ($)shares	Dec. 31, 2020USD ($)$ / sharesshares	Jul. 28, 2021USD ($)	Mar. 03, 2021USD ($)
Subsidiary, Sale of Stock [Line Items]
Condition for future business combination number of businesses minimum \| item		1
Sale of Units, net of underwriting discounts (in shares) \| shares					27,600,000		27,600,000
Sale of Private Placement Warrants (in shares) \| shares	7,520,000						21,320,000
Price of single warrant \| $ / shares	$ 1
Proceeds from sale of Private Placement Warrants	$ 7,520,000				$ 7,520,000	$ 0	$ 7,520,000
Transaction Costs	15,851,828		$ 0	$ 671,901	$ 671,901	0	15,851,828
Underwriting fees	5,520,000						5,520,000
Deferred underwriting fees	9,660,000		9,660,000			$ 9,660,000	9,660,000
Other offering costs	$ 671,828						671,828
Investment of Cash into Trust Account							$ 209,000
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account						80.00%	80.00%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination						50.00%	50.00%
Minimum net tangible assets upon consummation of the Business Combination			5,000,001			$ 5,000,001	$ 5,000,001
Threshold percentage of Public Shares subject to redemption without the Company's prior written consent						15.00%	15.00%
Obligation to redeem Public Shares if entity does not complete a Business Combination (as a percent)						100.00%	100.00%
Threshold business days for redemption of public shares						10 days	10 days
Maximum net interest to pay dissolution expenses						$ 100,000	$ 100,000
Cash			304,944			304,944	491,827
Operating bank accounts			276,178,675			276,178,675	276,209,453
Working capital deficit			2,265,312			2,265,312	897,026
Franchise tax payable			$ 150,000			$ 150,000	176,006
Investment of Cash into Trust Account							$ 209,000
Loans for working capital purpose								$ 4,000,000
Subsequent Event
Subsidiary, Sale of Stock [Line Items]
Loans for working capital purpose									$ 1,500,000
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares) \| shares	27,600,000					27,600,000	27,600,000
Unit price \| $ / shares	$ 10						$ 10
Proceeds from issuance of units	$ 276,000,000
Investment of Cash into Trust Account	$ 276,000,000
Investment maximum maturity term	185 days
Investment of Cash into Trust Account	$ 276,000,000
Private Placement
Subsidiary, Sale of Stock [Line Items]
Sale of Private Placement Warrants (in shares) \| shares	7,520,000						7,520,000
Price of single warrant \| $ / shares	$ 1						$ 1
Proceeds from sale of Private Placement Warrants	$ 7,520,000						$ 7,520,000
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares) \| shares	3,600,000					3,600,000	3,600,000
Unit price \| $ / shares	$ 10

RESTATEMENT OF PREVIOUSLY ISS_6

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS (Details) - USD ($)	3 Months Ended				6 Months Ended	8 Months Ended	9 Months Ended	11 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2020	Jun. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020	Jul. 07, 2020	Jun. 30, 2020	Mar. 31, 2020	Feb. 14, 2020	Feb. 13, 2020
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Minimum net tangible assets								$ 5,000,001
Balance Sheet as of December 31, 2020 (audited)
Class A common stock subject to possible redemption	$ 276,028,675			$ 276,087,639		$ 276,087,639	$ 276,028,675	276,033,447	$ 276,000,000
Additional paid-in capital	0						0	0
Accumulated deficit	(44,312,150)			(25,533,547)		(25,533,547)	(44,312,150)	(40,659,524)	(26,004,118)
Total stockholders' equity (deficit)	(44,311,460)	$ (30,073,974)	$ (26,026,715)	(25,532,857)	$ (30,073,974)	$ (25,532,857)	(44,311,460)	$ (40,658,834)		$ 24,000	$ 24,000	$ 0	$ 0
Statement of Operations
Basic and diluted weighted average shares outstanding (in shares)								8,269,814
Basic and diluted net income per share, Class B common stock								$ (1.85)
Statement of Changes in Shareholders' Equity (Deficit)
Sale of 27,600,000 Units, net of underwriting discounts (in shares)						27,600,000		27,600,000
Accretion for Class A ordinary share subject to redemption amount						$ (26,721,566)		$ (26,721,566)
Total stockholders' equity (deficit)	(44,311,460)	(30,073,974)	(26,026,715)	$ (25,532,857)	(30,073,974)	$ (25,532,857)	(44,311,460)	(40,658,834)		$ 24,000	$ 24,000	$ 0	$ 0
Class A common stock
Balance Sheet as of December 31, 2020 (audited)
Class A common stock	$ 0						$ 0	$ 0
Number of shares subject to redemption								27,600,000
Statement of Operations
Basic and diluted weighted average shares outstanding (in shares)	27,600,000			25,780,220		10,761,468	27,600,000	15,758,710
Basic and diluted net income per share, Class B common stock	$ (0.41)			$ 0		$ (0.01)	$ (0.11)	$ (0.69)
Class A common stock subject to possible redemption
Balance Sheet as of December 31, 2020 (audited)
Number of shares subject to redemption	27,600,000						27,600,000	27,600,000
Class B common stock
Balance Sheet as of December 31, 2020 (audited)
Class A common stock	$ 690						$ 690	$ 690
Statement of Operations
Basic and diluted weighted average shares outstanding (in shares)	6,900,000			6,840,659		6,350,917	6,900,000	6,513,871
Basic and diluted net income per share, Class B common stock	$ (0.41)			$ 0		$ (0.01)	$ (0.11)	$ (0.69)
As Previously Reported
Balance Sheet as of December 31, 2020 (audited)
Class A common stock subject to possible redemption		240,972,620	245,061,587	$ 245,554,779	240,972,620	$ 245,554,779		$ 230,374,604	244,996,570
Class A common stock		352	311	305	352	305		457	310
Additional paid-in capital		9,695,811	5,606,885	5,113,699	9,695,811	5,113,699		20,293,722	5,671,903
Accumulated deficit		(4,696,850)	(607,876)	(114,691)	(4,696,850)	(114,691)		(15,294,860)	(672,901)
Total stockholders' equity (deficit)		$ 5,000,003	$ 5,000,010	$ 5,000,003	$ 5,000,003	$ 5,000,003		$ 5,000,009	$ 5,000,002
Number of shares subject to redemption		24,084,470	24,493,884	24,547,683	24,084,470	24,547,683		23,034,669	24,499,657
Statement of Changes in Shareholders' Equity (Deficit)
Sale of 27,600,000 Units, net of underwriting discounts						$ 249,366,073		$ 249,366,073
Class A common stock subject to possible redemption		$ 5,000,003	$ 5,000,010			5,000,003		5,000,009
Total stockholders' equity (deficit)		$ 5,000,003	5,000,010	$ 5,000,003	$ 5,000,003	5,000,003		5,000,009	$ 5,000,002
Statement of Cash Flows
Initial classification of Class A common stock subject to possible redemption						244,996,570		244,996,570
Change in value of Class A common stock subject to possible redemption			$ 14,686,983		$ 10,598,016	$ 558,209		$ (14,621,966)
As Previously Reported \| Class A common stock subject to possible redemption
Statement of Operations
Basic and diluted weighted average shares outstanding (in shares)		24,493,884	23,034,669		23,768,307	24,499,657		24,524,620
Basic and diluted net income per share, Class B common stock			$ 1.28
Statement of Changes in Shareholders' Equity (Deficit)
Class A common stock subject to possible redemption		$ (4,088,967)	$ (14,686,983)			$ (245,554,775)		$ (230,374,604)
As Previously Reported \| Common Stock Not Subject to Redemption
Statement of Operations
Basic and diluted weighted average shares outstanding (in shares)		10,006,116	11,465,331		10,731,693	7,559,767		8,269,814
Basic and diluted net income per share, Class B common stock		$ (0.41)			$ 0.99	$ (0.02)		$ (1.85)
Adjustment
Balance Sheet as of December 31, 2020 (audited)
Class A common stock subject to possible redemption		$ 35,073,977	$ 31,026,725	30,532,860	$ 35,073,977	$ 30,532,860		$ 45,658,843	31,003,430
Class A common stock		(352)	(311)	(305)	(352)	(305)		(457)	(310)
Additional paid-in capital		(9,695,811)	(5,606,885)	(5,113,699)	(9,695,811)	(5,113,699)		(20,293,722)	(5,671,903)
Accumulated deficit		(25,377,814)	(25,419,529)	(25,418,856)	(25,377,814)	(25,418,856)		(25,364,664)	(25,331,217)
Total stockholders' equity (deficit)		$ (35,073,977)	$ (31,026,725)	$ (30,532,860)	$ (35,073,977)	$ (30,532,860)		$ (45,658,843)	$ (31,003,430)
Number of shares subject to redemption		3,515,530	3,106,116	3,052,317	3,515,530	3,052,317		4,565,331	3,100,343
Statement of Changes in Shareholders' Equity (Deficit)
Sale of 27,600,000 Units, net of underwriting discounts						$ (249,366,073)		$ (249,366,073)
Class A common stock subject to possible redemption		$ (35,073,977)	$ (31,026,725)			(30,532,860)		(45,658,843)
Accretion for Class A ordinary share subject to redemption amount		41,715	(54,865)
Total stockholders' equity (deficit)		$ (35,073,977)	(31,026,725)	$ (30,532,860)	$ (35,073,977)	(30,532,860)		(45,658,843)	$ (31,003,430)
Statement of Cash Flows
Initial classification of Class A common stock subject to possible redemption						31,003,430		31,003,430
Change in value of Class A common stock subject to possible redemption			$ (14,598,671)		$ (10,551,419)	$ (470,570)		$ 14,655,413
Adjustment \| Class A common stock
Statement of Operations
Basic and diluted weighted average shares outstanding (in shares)		27,600,000	27,600,000		27,600,000	10,761,468		15,758,710
Basic and diluted net income per share, Class B common stock			$ 0.43		$ 0.31	$ (0.01)		$ (0.69)
Adjustment \| Class A common stock subject to possible redemption
Statement of Operations
Basic and diluted weighted average shares outstanding (in shares)		(24,493,884)	(23,034,669)		(23,768,307)	(24,499,657)		(24,524,620)
Basic and diluted net income per share, Class B common stock			$ (1.28)
Statement of Changes in Shareholders' Equity (Deficit)
Sale of 27,600,000 Units, net of underwriting discounts						$ (26,721,566)		$ (26,721,566)
Class A common stock subject to possible redemption		$ 4,088,967	$ 14,686,983			$ 245,554,775		$ 230,374,604
Adjustment \| Common Stock Not Subject to Redemption
Statement of Operations
Basic and diluted weighted average shares outstanding (in shares)		(10,006,116)	(11,465,331)		(10,731,693)	(7,559,767)		(8,269,814)
Basic and diluted net income per share, Class B common stock		$ 0.41			$ (0.99)	$ 0.02		$ 1.85
Adjustment \| Class B common stock
Statement of Operations
Basic and diluted weighted average shares outstanding (in shares)		6,900,000	6,900,000		6,900,000	6,350,917		6,513,871
Basic and diluted net income per share, Class B common stock		$ (0.59)	$ 0.43		$ 0.31	$ (0.01)		$ (0.69)
As Restated
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Minimum net tangible assets							$ 5,000,001
Balance Sheet as of December 31, 2020 (audited)
Class A common stock subject to possible redemption		$ 276,046,597	$ 276,088,312	276,087,639	$ 276,046,597	$ 276,087,639		$ 276,033,447	276,000,000
Accumulated deficit		(30,074,664)	(26,027,405)	(25,533,547)	(30,074,664)	(25,533,547)		(40,659,524)	(26,004,118)
Total stockholders' equity (deficit)		$ (30,073,974)	$ (26,026,715)	$ (25,532,857)	$ (30,073,974)	$ (25,532,857)		$ (40,658,834)	$ (26,003,428)
Number of shares subject to redemption		27,600,000	27,600,000	27,600,000	27,600,000	27,600,000		27,600,000	27,600,000
Statement of Changes in Shareholders' Equity (Deficit)
Class A common stock subject to possible redemption		$ (30,073,974)	$ (26,026,715)			$ (25,532,857)		$ (40,658,834)
Accretion for Class A ordinary share subject to redemption amount		41,715	(54,865)
Total stockholders' equity (deficit)		$ (30,073,974)	(26,026,715)	$ (25,532,857)	$ (30,073,974)	(25,532,857)		(40,658,834)	$ (26,003,428)
Statement of Cash Flows
Initial classification of Class A common stock subject to possible redemption						276,000,000		276,000,000
Change in value of Class A common stock subject to possible redemption			$ 88,312		$ 46,597	$ 87,639		$ 33,447
As Restated \| Class A common stock
Statement of Operations
Basic and diluted weighted average shares outstanding (in shares)		27,600,000	27,600,000		27,600,000	10,761,468		15,758,710
Basic and diluted net income per share, Class B common stock			$ 0.43		$ 0.31	$ (0.01)		$ (0.69)
As Restated \| Class A common stock subject to possible redemption
Statement of Changes in Shareholders' Equity (Deficit)
Sale of 27,600,000 Units, net of underwriting discounts						$ (26,721,566)		$ (26,721,566)
As Restated \| Class B common stock
Statement of Operations
Basic and diluted weighted average shares outstanding (in shares)		6,900,000	6,900,000		6,900,000	6,350,917		6,513,871
Basic and diluted net income per share, Class B common stock		$ (0.59)	$ 0.43		$ 0.31	$ (0.01)		$ (0.69)

SUMMARY OF SIGNIFICANT ACCOU_11

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	9 Months Ended	11 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Dec. 31, 2020
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash equivalents	$ 0	$ 0	$ 0
Unrecognized tax benefits	0	0	0
Unrecognized tax benefits accrued for interest and penalties	$ 0	$ 0	0
Statutory tax rate (as a percent)		21.00%
Anti-dilutive securities attributable to warrants (in shares)	21,320,000	21,320,000
Cash, FDIC Insured Amount	$ 250,000	$ 250,000	250,000
Gross proceeds			276,000,000
Proceeds allocated to Public Warrants		11,454,000	(11,454,000)
Ordinary shares issuance costs		(15,179,927)	(15,179,714)
Ordinary shares subject to possible redemption, beginning	276,033,447
Accretion of carrying value to redemption value	(4,772)	(26,667,374)	(26,667,374)
Ordinary shares subject to possible redemption, ending	$ 276,028,675	$ 276,033,447	$ 276,033,447

SUMMARY OF SIGNIFICANT ACCOU_12

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Calculation of Basic and Diluted Net Income (Loss) Per Common Share (Details) - USD ($)	3 Months Ended		8 Months Ended	9 Months Ended	11 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Denominator:
Basic and diluted weighted average shares outstanding (in shares)					8,269,814
Basic and diluted net income (loss) per share (in dollars per share)					$ (1.85)
Class A Common Stock
Numerator:
Allocation of net income (loss), as adjusted	$ (11,404,326)	$ (89,850)	$ (72,126)	$ (2,925,918)
Denominator:
Basic and diluted weighted average shares outstanding (in shares)	27,600,000	25,780,220	10,761,468	27,600,000
Basic and diluted net income (loss) per share (in dollars per share)	$ (0.41)	$ 0	$ (0.01)	$ (0.11)
Class B Common Stock
Numerator:
Allocation of net income (loss), as adjusted	$ (2,851,082)	$ (23,841)	$ (42,565)	$ (731,480)
Denominator:
Basic and diluted weighted average shares outstanding (in shares)	6,900,000	6,840,659	6,350,917	6,900,000
Basic and diluted net income (loss) per share (in dollars per share)	$ (0.41)	$ 0	$ (0.01)	$ (0.11)

PUBLIC OFFERING (Details)_2

PUBLIC OFFERING (Details) - $ / shares	Jul. 07, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)		27,600,000		27,600,000
Number of shares issuable per warrant	1
Exercise price of warrants	$ 11.50
Initial Public Offering
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)	27,600,000		27,600,000	27,600,000
Price per share			$ 10	$ 10
Number of shares in a unit			1	1
Number of warrants in a unit			0.5	0.5
Number of shares issuable per warrant			1	1
Exercise price of warrants			$ 11.50	$ 11.50
Over-allotment option
Subsidiary, Sale of Stock [Line Items]
Sale of Units, net of underwriting discounts (in shares)	3,600,000		3,600,000	3,600,000

PRIVATE PLACEMENT (Details)_2

PRIVATE PLACEMENT (Details) - USD ($)	Jul. 07, 2020	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued	7,520,000			21,320,000
Price of warrants	$ 1
Aggregate purchase price	$ 7,520,000	$ 7,520,000	$ 0	$ 7,520,000
Number of shares per warrant	1
Exercise price of warrant	$ 11.50
Private Placement
Subsidiary, Sale of Stock [Line Items]
Number of warrants to purchase shares issued	7,520,000			7,520,000
Price of warrants	$ 1			$ 1
Aggregate purchase price	$ 7,520,000			$ 7,520,000

RELATED PARTY TRANSACTIONS - _2

RELATED PARTY TRANSACTIONS - Founder Shares (Details)	Jul. 01, 2020D$ / sharesshares	Feb. 26, 2020USD ($)shares	Mar. 31, 2020USD ($)	Mar. 31, 2020USD ($)
Related Party Transaction [Line Items]
Aggregate purchase price \| $			$ 25,000	$ 25,000
Founder Shares \| Sponsor \| Class B common stock
Related Party Transaction [Line Items]
Number of shares issued		5,750,000
Aggregate purchase price \| $		$ 25,000
Share dividend	1,150,000
Aggregate number of shares owned	6,900,000
Shares subject to forfeiture	900,000
Percentage of issued and outstanding shares after the Initial Public Offering collectively held by initial stockholders	20.00%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	1 year
Stock price trigger to transfer, assign or sell any shares or warrants of the company, after the completion of the initial business combination (in dollars per share) \| $ / shares	$ 12
Threshold trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| D	20
Threshold consecutive trading days for transfer, assign or sale of shares or warrants, after the completion of the initial business combination \| D	30
Threshold period after the business combination in which the 20 trading days within any 30 trading day period commences	150 days

RELATED PARTY TRANSACTIONS - _3

RELATED PARTY TRANSACTIONS - Additional Information (Details) - USD ($)	Jul. 07, 2020	Jul. 01, 2020	Feb. 14, 2020	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Dec. 31, 2020	Jul. 28, 2021	Mar. 03, 2021	Feb. 14, 2021
Related Party Transaction [Line Items]
Repayment of promissory note - related party					$ 150,000	$ 0	$ 150,000
Loans for working capital purpose								$ 4,000,000
Promissory Note with Related Party
Related Party Transaction [Line Items]
Maximum borrowing capacity of related party promissory note			$ 250,000							$ 250,000
Repayment of promissory note - related party	$ 140,000		$ 150,000
Administrative Support Agreement
Related Party Transaction [Line Items]
Expenses per month		$ 10,000
Expenses incurred				$ 30,000		90,000
Expenses incurred and paid							60,000
Account payable and accrued expense related to related party				10,000		10,000
Related Party Loans
Related Party Transaction [Line Items]
Maximum Loans Convertible Into Warrants				$ 1,500,000		$ 1,500,000	$ 1,500,000
Price of warrants (in dollars per share)				$ 1		$ 1	$ 1
Loans for working capital purpose									$ 1,500,000
Sponsor Loan
Related Party Transaction [Line Items]
Aggregate amount of loan								$ 4,000,000
Amount outstanding				$ 0		$ 0
Subsequent Event
Related Party Transaction [Line Items]
Loans for working capital purpose									$ 1,500,000

COMMITMENTS (Details)_2

COMMITMENTS (Details)	Sep. 30, 2021USD ($)$ / shares	Dec. 31, 2020USD ($)$ / shares	Jul. 07, 2020USD ($)	Jul. 01, 2020item
COMMITMENTS
Maximum number of demands for registration of securities \| item				3
Deferred fee per unit \| $ / shares	$ 0.35	$ 0.35
Deferred underwriting fee payable \| $	$ 9,660,000	$ 9,660,000	$ 9,660,000

COMMITMENTS - Additional Inform

COMMITMENTS - Additional Information (Details)	Nov. 08, 2021USD ($)shares	Jul. 19, 2021USD ($)$ / sharesshares	Sep. 30, 2021$ / shares	Dec. 31, 2020$ / shares	Feb. 26, 2020$ / shares
Class A common stock
Subsequent Event [Line Items]
Common shares, par value (in dollars per share)			$ 0.0001	$ 0.0001	$ 0.0001
Class B common stock
Subsequent Event [Line Items]
Common shares, par value (in dollars per share)			$ 0.0001	$ 0.0001	$ 0.0001
Gelesis
Subsequent Event [Line Items]
Common shares, par value (in dollars per share)		$ 0.0001
Implied equity value \| $		$ 900,000,000
Conversion ratio of CPSR Class A or CPSR Class B to CPSR Share		1
Trading price for future vesting threshold of the first third		$ 12.50
Trading price for future vesting threshold of the second third		15
Trading price for future vesting threshold of the third portion		$ 17.50
Number of trading days within specified period that share price must exceed		20 days
Consecutive trading days used to evaluate share price		30 days
Threshold period before share price condition commences		5 years
Number of pro rata portion of restricted earn out CPSR shares will be received by each holder of common stock, options and warrants \| shares		15,000,000
Gelesis \| Class A common stock
Subsequent Event [Line Items]
Common shares, par value (in dollars per share)		$ 0.0001
Gelesis \| Class B common stock
Subsequent Event [Line Items]
Common shares, par value (in dollars per share)		0.0001
Subsequent Event
Subsequent Event [Line Items]
Trading price for future vesting threshold of the first third		20
Trading price for future vesting threshold of the second third		$ 20
Subsequent Event \| Gelesis \| Maximum [Member]
Subsequent Event [Line Items]
Implied equity value \| $	$ 675,000,000
Number of pro rata portion of restricted earn out CPSR shares will be received by each holder of common stock, options and warrants \| shares	23,483,250
Subsequent Event \| Gelesis \| Minimum [Member]
Subsequent Event [Line Items]
Implied equity value \| $	$ 900,000,000
Number of pro rata portion of restricted earn out CPSR shares will be received by each holder of common stock, options and warrants \| shares	15,000,000
Subsequent Event \| Gelesis \| Class A common stock
Subsequent Event [Line Items]
Additional number of earn out shares \| shares	1,983,750
Subsequent Event \| Sponsor \| Gelesis \| Class B common stock
Subsequent Event [Line Items]
Number of pro rata portion of restricted earn out CPSR shares will be received by each holder of common stock, options and warrants \| shares	1,983,750

STOCKHOLDERS' EQUITY - Preferre

STOCKHOLDERS' EQUITY - Preferred Stock Shares (Details) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
STOCKHOLDERS' DEFICIT
Preferred shares, shares authorized	1,000,000	1,000,000
Preferred shares, par value	$ 0.0001	$ 0.0001
Preferred shares, shares issued	0	0
Preferred shares, shares outstanding	0	0

STOCKHOLDERS' EQUITY - Common S

STOCKHOLDERS' EQUITY - Common Stock Shares (Details)	Sep. 30, 2021$ / sharesshares	Dec. 31, 2020$ / sharesshares	Feb. 26, 2020Vote$ / sharesshares
Class of Stock [Line Items]
Class A common stock subject to possible redemption, issued (in shares)		27,600,000
Class A common stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	100,000,000	100,000,000	100,000,000
Common shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Common shares, votes per share \| Vote			1
Common shares, shares issued (in shares)	0	0
Common shares, shares outstanding (in shares)	0	0
Class A common stock subject to possible redemption, issued (in shares)		26,044,485
Class A common stock subject to possible redemption
Class of Stock [Line Items]
Common shares, shares issued (in shares)	27,600,000	27,600,000
Common shares, shares outstanding (in shares)	27,600,000	27,600,000
Class B common stock
Class of Stock [Line Items]
Common shares, shares authorized (in shares)	10,000,000	10,000,000	10,000,000
Common shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Common shares, votes per share \| Vote			1
Common shares, shares issued (in shares)	6,900,000	6,900,000
Common shares, shares outstanding (in shares)	6,900,000	6,900,000
Threshold conversion ratio of stock	20.00%	20.00%

WARRANTS (Details)_2

WARRANTS (Details)	9 Months Ended	11 Months Ended
WARRANTS (Details)	Sep. 30, 2021D$ / sharesshares	Dec. 31, 2020Ditem$ / sharesshares
Warrants
Class of Warrant or Right [Line Items]
Public Warrants exercisable term after the completion of a business combination	30 days	30 days
Public Warrants exercisable term from the closing of the initial public offering	12 months	12 months
Public Warrants expiration term	5 years	5 years
Threshold period for filling registration statement after business combination	15 days	15 days
Threshold period for registration statement to be effective after which warrants can be exercised on a cashless basis	60 days	60 days
Threshold issue price for capital raising purposes in connection with the closing of a Business Combination	$ 9.20	$ 9.20
Percentage of gross proceeds on total equity proceeds	60.00%	60.00%
Threshold trading days for calculating Market Value	20	20
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115.00%	115.00%
Adjustment two of redemption price of stock based on market value and newly issued price (as a percent)	180.00%	180.00%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days	30 days
Warrants \| Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Class of Warrant or Right [Line Items]
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18	$ 18
Redemption price per public warrant (in dollars per share)	$ 0.01	$ 0.01
Minimum threshold written notice period for redemption of public warrants \| D	30
Threshold trading days for redemption of public warrants \| D	20	20
Threshold number of business days before sending notice of redemption to warrant holders	3	3
Redemption period	30 days	30 days
Public Warrants
Class of Warrant or Right [Line Items]
Number of warrants outstanding \| shares	13,800,000	13,800,000
Private Placement Warrants
Class of Warrant or Right [Line Items]
Number of warrants outstanding \| shares	7,520,000	7,520,000

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details) - USD ($)	Sep. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jul. 07, 2020
Liabilities:
Warrant liabilities	$ 32,386,148	$ 30,101,808	$ 17,081,700	$ 17,695,600
Level 1 \| Recurring
Assets:
Cash and marketable securities held in Trust Account	276,178,675	276,209,453
Level 1 \| Recurring \| Public Warrants
Liabilities:
Warrant liabilities	12,006,000	19,458,000
Level 3 \| Recurring \| Private Placement Warrants
Liabilities:
Warrant liabilities	$ 20,380,148	$ 10,643,808

FAIR VALUE MEASUREMENTS - Level

FAIR VALUE MEASUREMENTS - Level 3 Fair Value Measurements Inputs (Details)	Sep. 30, 2021item	Dec. 31, 2020item	Jul. 07, 2020$ / shares
Risk-free interest rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	1.02	0.47
Expected Term
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	5.25	5.76
Dividend yield
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0	0
Expected volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	13.5	19
Exercise price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	11.50	11.50
Unit Price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	9.92	10.15
Level 3 \| Risk-free interest rate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input			0.39
Level 3 \| Dividend yield
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input			0
Level 3 \| Expected volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input			10
Level 3 \| Exercise price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input \| $ / shares			11.50

FAIR VALUE MEASUREMENTS - Chang

FAIR VALUE MEASUREMENTS - Change in the Fair Value of the Warrant Liabilities (Details) - USD ($)	3 Months Ended			11 Months Ended
	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value as of beginning			$ 30,101,808
Change in fair value				$ 12,406,208
Fair value as of ending				30,101,808
Private Placement Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value as of beginning	$ 6,793,384	$ 5,370,784	10,643,808
Change in fair value	13,586,764	1,422,600	(5,273,024)	4,402,208
Fair value as of ending	$ 20,380,148	$ 6,793,384	5,370,784	10,643,808
Public Warrants
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value as of beginning			$ 19,458,000
Change in fair value				8,004,000
Fair value as of ending				$ 19,458,000

FAIR VALUE MEASUREMENTS - Addit

FAIR VALUE MEASUREMENTS - Additional Information (Details) - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
FAIR VALUE MEASUREMENTS
Fair value assets transferred into (out of) level 3	$ 0
Fair value of Private Placement Warrants	$ 2.71	$ 1.42